Sinoatrial Node Dysfunction and Deafness

Mendelian MONDO:0013960 Pathograph 16 Show in embeddings browser Cardiac Arrhythmia Channelopathy

Sinoatrial node dysfunction and deafness (SANDD) is an ultra-rare autosomal recessive human channelopathy caused by biallelic loss-of-function variants in CACNA1D, which encodes the pore-forming alpha-1D subunit of the Cav1.3 L-type voltage-gated calcium channel. It is mechanistically elegant because a single channel lesion produces two clinically unrelated manifestations in two tissues: Cav1.3 carries the low-threshold, slowly inactivating L-type calcium current that contributes to diastolic depolarization in sinoatrial node pacemaker cells, and the same channel supplies the calcium influx that triggers glutamate release at the cochlear inner hair cell ribbon synapse. Affected individuals therefore present with congenital severe-to-profound sensorineural deafness (with no evidence of vestibular dysfunction) together with pronounced resting bradycardia, increased resting heart-rate variability, and episodic syncope that may be triggered by exertion or emotional stress. The disorder was defined in consanguineous Pakistani families, in which a founder in-frame glycine insertion near the channel pore (c.1208_1209insGGG, p.Gly403_Val404insGly) yields non-conducting Cav1.3 channels; the human phenotype closely recapitulates the Cacna1d-null mouse. Heterozygous carriers of the SANDD alleles are unaffected, which distinguishes SANDD from the dominant CACNA1D gain-of-function disorders (primary aldosteronism with seizures and neurologic abnormalities, autism spectrum disorder, and a sinus-node-dysfunction/epilepsy syndrome) that arise at the same locus.

Ask OpenScientist

Ask a research question about Sinoatrial Node Dysfunction and Deafness. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

1
Mappings
1
Inheritance
10
Pathophys.
8
Phenotypes
1
Hypotheses
3
Gaps
16
Pathograph
2
Genes
4
Medical Actions
1
Deep Research
🏷

Classifications

Harrison's Part
CARDIOVASCULAR NEUROLOGIC GENETICS ENVIRONMENT DISEASE
Channelopathy
cardiac channelopathy
🔗

Mappings

MONDO
MONDO:0013960 sinoatrial node dysfunction and deafness
skos:exactMatch MONDO
MONDO:0013960 is the primary disease term for this entry, cross-referenced to OMIM:614896 and Orphanet:324321, with CACNA1D (HGNC:1391) asserted as the causal gene.
👪

Inheritance

1
Autosomal Recessive HP:0000007
SANDD is inherited in an autosomal recessive manner. All reported families are consanguineous Pakistani pedigrees in which affected individuals are homozygous for a CACNA1D loss-of-function allele; heterozygous carriers, including the obligate-carrier parents, are clinically unaffected with respect to both hearing and heart rate. Four of the five families in the replication cohort share a 1.03 Mb haplotype around the founder p.Gly403_Val404insGly allele, indicating a common distant ancestor. Carrier couples face the standard 25% per-pregnancy recurrence risk.
Autosomal recessive inheritance
Show evidence (3 references)
PMID:21131953 SUPPORT Human Clinical
"We used positional cloning to identify a mutation in CACNA1D, which encodes the pore-forming α1 subunit of Ca(v)1.3 LTCCs, in two consanguineous families with deafness."
Positional cloning in consanguineous pedigrees establishes the recessive architecture of the disorder.
PMID:30498240 SUPPORT Human Clinical
"We show that affected individuals in the four families which segregate p.(G403_V404insG) share a 1.03 MB haplotype on 3p21.1 suggesting they share a common distant ancestor."
Shared-haplotype analysis across four additional consanguineous pedigrees confirms recessive segregation of a founder allele.
PMID:36430690 SUPPORT Human Clinical
"So far, homozygous loss of function mutations in CACNA1D encoding the Cav1.3 α1-subunit are described in congenital sinus node dysfunction and deafness."
Independent confirmation that the SANDD phenotype requires homozygous (biallelic) loss of function, distinguishing it from the heterozygous CACNA1D presentations.
◈

Mechanistic Hypotheses

1
Single-Channel Two-Tissue Divergence Model
cav1_3_two_tissue_divergence CANONICAL
Evidence balance 3 support
One Cav1.3 loss-of-function lesion produces two clinically unrelated manifestations because the same low-voltage-activated, slowly inactivating L-type calcium channel performs two non-redundant jobs in two tissues: contributing inward current to diastolic depolarization in sinoatrial node pacemaker cells (yielding bradycardia and sinoatrial node dysfunction), and supplying the presynaptic calcium influx that triggers graded glutamate release at the cochlear inner hair cell ribbon synapse (yielding congenital deafness). Neither job can be taken over by the co-expressed Cav1.2 channel, whose more depolarized activation threshold is unsuitable for either. The human phenotype closely recapitulates the Cacna1d-null mouse, which supports the model rather than a species-specific mechanism.
Show evidence (3 references)
PMID:21131953 SUPPORT Other
"Ca(v)1.3 voltage-gated L-type calcium channels (LTCCs) translate sound-induced depolarization into neurotransmitter release in auditory hair cells and control diastolic depolarization in the mouse sinoatrial node (SAN)."
Names both tissue-specific roles of the single channel, the premise of the divergence model.
PMID:21131953 SUPPORT Human Clinical
"We describe a human channelopathy (termed SANDD syndrome, sinoatrial node dysfunction and deafness) with a cardiac and auditory phenotype that closely resembles that of Cacna1d(-/-) mice."
Confirms that the two-arm human phenotype matches the null mouse, supporting a shared single-channel mechanism.
PMID:10929716 SUPPORT Model Organism
"We conclude that alpha1D can form LTCCs with negative activation thresholds essential for normal auditory function and control of cardiac pacemaker activity."
The genetic null demonstrates that the negative activation threshold of Cav1.3 is required for both functions, explaining the non-redundancy.
?

Discussions and Knowledge Gaps

3
Why is vestibular function spared in SANDD when cochlear inner hair cell transmission fails, given that vestibular hair cells also use ribbon synapses? Do vestibular hair cells rely on a different calcium channel complement (for example a larger Cav1.2 contribution) or on a Cav1.3-independent release mode?
KNOWLEDGE GAP OPEN gap_sandd_vestibular_sparing
Attached to
pathophysiology#Loss of Cav1.3 Calcium Current at the Inner Hair Cell Ribbon Synapse
Both the MONDO definition and the clinical reports emphasize that affected individuals have no evidence of vestibular dysfunction despite congenital profound cochlear deafness. Vestibular hair cells use morphologically similar ribbon synapses, so their sparing implies a genuine molecular difference in the calcium channel complement or in the coupling between channels and release sites. Resolving this would refine the mechanism and would matter for any future channel-targeted therapy.
Proposed experiments
Comparative calcium-channel profiling of cochlear versus vestibular hair cells
exp_sandd_vestibular_channel_complement
Quantify Cav1.3 versus Cav1.2 expression and the calcium current carried by each in cochlear inner hair cells and in utricular/saccular vestibular hair cells from the same animals, and repeat in a Cav1.3-null background to establish which release sites remain functional.
Does hair cell degeneration actually occur in the human SANDD cochlea, or is the human deafness a pure synaptopathy with a structurally preserved organ of Corti? This determines whether cochlear implantation should be expected to work as well as in other congenital deafness, and whether a presynaptic-targeted therapy could ever be viable.
HUMAN MODEL MISMATCH OPEN gap_sandd_human_cochlear_degeneration
Attached to
pathophysiology#Failure of Auditory Synaptic Transmission and Hair Cell Degeneration
Hair cell degeneration in Cav1.3 deficiency is documented only in the Cacna1d-null mouse; no human cochlear histopathology or spiral-ganglion imaging has been reported in SANDD. The distinction matters clinically: a pure presynaptic synaptopathy with an intact spiral ganglion is the ideal substrate for cochlear implantation, whereas secondary degeneration extending to the ganglion would predict poorer outcomes. The mouse data sharpen rather than settle the question, and they point the wrong way for implant candidacy: ribbon synapses are initially built and preserved, but the Cav1.3-deficient inner hair cells later lose their afferent synapses, probably through secondary degeneration of the postsynaptic spiral ganglion neurons (PMID:16828974). If that sequence holds in humans there may be a time-limited window in which the auditory nerve is still implantable. The question also determines whether the auditory arm is in principle reversible by restoring channel function.
Proposed experiments
Electrophysiological and imaging phenotyping of the SANDD auditory pathway
exp_sandd_auditory_neuropathy_workup
In genotyped SANDD individuals, combine otoacoustic emissions (to test outer hair cell integrity), auditory brainstem response and electrocochleography (to localize the block to the synapse versus the nerve), and high-resolution cochlear MRI/CT, then correlate with cochlear implant outcomes.
Does human SANDD include clinically significant atrioventricular conduction disease, up to complete heart block, as the Cav1.3-null mouse does, and if so at what frequency and at what age?
HUMAN MODEL MISMATCH OPEN gap_sandd_human_av_block
Attached to
pathophysiology#Atrioventricular Conduction Slowing
Cav1.3-null mice show frank atrioventricular block, and review literature describes atrioventricular conduction disease within the Cav1.3 channelopathy spectrum, but the abstract-level human evidence in SANDD extends only to a single observation that P waves did not regularly precede the QRS. This matters directly for device selection: isolated sinus node dysfunction may be treated with atrial pacing, whereas coexisting atrioventricular block requires dual-chamber pacing. Systematic Holter and electrophysiological characterization of genotyped individuals would resolve it.
Proposed experiments
Systematic conduction-system phenotyping of genotyped SANDD individuals
exp_sandd_conduction_phenotyping
Perform 12-lead ECG, 24-48 hour Holter, exercise testing for chronotropic competence, and where clinically indicated invasive electrophysiological study (AH and HV intervals) across the known SANDD pedigrees, reporting per-individual atrioventricular conduction status by genotype.
⚙

Pathophysiology

10
Biallelic CACNA1D Loss of Function
Homozygous CACNA1D loss-of-function variants abolish conduction through the Cav1.3 L-type voltage-gated calcium channel. The founder allele inserts an extra glycine into a highly conserved, alternatively spliced segment near the channel pore and yields channels that reach the membrane but do not conduct calcium and show abnormal voltage-dependent gating. Because Cav1.3 is the low-voltage-activated, slowly inactivating member of the L-type family, its loss cannot be compensated by the co-expressed Cav1.2 channel in either of the two tissues that depend on it.
CACNA1D hgnc:1391 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves CACNA1D (hgnc:1391). hgnc:1391 is a gene from the HUGO Gene Nomenclature Committee.
calcium ion transmembrane transport GO:0070588 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased calcium ion transmembrane transport (GO:0070588). GO:0070588 is a biological process from the Gene Ontology. ↓ DECREASED
voltage-gated calcium channel activity GO:0005245 Gene Ontology (GO) Relation: this pathophysiological event involves this molecular function This pathophysiological event involves decreased voltage-gated calcium channel activity (GO:0005245). GO:0005245 is a molecular function from the Gene Ontology. ↓ DECREASED
Downstream
Loss of Cav1.3 Calcium Current in Sinoatrial Pacemaker Cells Non-conducting Cav1.3 channels remove the low-threshold L-type calcium current that contributes inward charge during the diastolic depolarization of sinoatrial node pacemaker cells.
Loss of Cav1.3 Calcium Current at the Inner Hair Cell Ribbon Synapse The same non-conducting channels remove the presynaptic calcium influx on which glutamate release at the cochlear inner hair cell ribbon synapse depends.
Show evidence (2 references)
PMID:21131953 SUPPORT In Vitro
"The insertion of a glycine residue in a highly conserved, alternatively spliced region near the channel pore resulted in nonconducting calcium channels that had abnormal voltage-dependent gating."
Direct functional evidence that the SANDD founder allele produces non-conducting Cav1.3 channels.
PMID:27374078 SUPPORT Other
"Mutation in the CACNA1D gene encoding Cav 1.3 channels induces loss-of-function in channel activity and underlies the sino-atrial node dysfunction and deafness syndrome (SANDD)."
Review confirms channel loss of function as the proximate trigger of SANDD.
Loss of Cav1.3 Calcium Current in Sinoatrial Pacemaker Cells
In sinoatrial node pacemaker cells the slow diastolic depolarization that sets the intrinsic firing rate is built from several inward currents, including the Cav1.3 L-type calcium current, which activates at unusually negative potentials (close to -55 mV under adrenergic activation). Loss of that current slows the rate of diastolic depolarization and delays the time at which the pacemaker cell reaches threshold, reducing intrinsic automaticity. In the Cav1.3-null mouse the sinoatrial L-type current density falls by 60-70%, quantifying the size of the lesion.
cardiac pacemaker cell of sinoatrial node CL:1000477 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves cardiac pacemaker cell of sinoatrial node (CL:1000477). CL:1000477 is a cell type from the Cell Ontology.
membrane depolarization during SA node cell action potential GO:0086046 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased membrane depolarization during SA node cell action potential (GO:0086046). GO:0086046 is a biological process from the Gene Ontology. ↓ DECREASED
voltage-gated calcium channel activity involved SA node cell action potential GO:0086059 Gene Ontology (GO) Relation: this pathophysiological event involves this molecular function This pathophysiological event involves decreased voltage-gated calcium channel activity involved SA node cell action potential (GO:0086059). GO:0086059 is a molecular function from the Gene Ontology. ↓ DECREASED
sinoatrial node UBERON:0002351 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in sinoatrial node (UBERON:0002351). UBERON:0002351 is an anatomical location from the Uberon multi-species anatomy ontology.
Downstream
Sinoatrial Node Pacemaker Dysfunction Slowed diastolic depolarization in individual pacemaker cells translates into depressed automaticity of the sinoatrial node as a whole.
Atrioventricular Conduction Slowing Cav1.3 is expressed in atrioventricular as well as sinoatrial nodal tissue, so the same current loss slows atrioventricular conduction.
Show evidence (3 references)
PMID:21131953 SUPPORT Other
"Ca(v)1.3 voltage-gated L-type calcium channels (LTCCs) translate sound-induced depolarization into neurotransmitter release in auditory hair cells and control diastolic depolarization in the mouse sinoatrial node (SAN)."
States the two tissue-specific roles of Cav1.3, including control of diastolic depolarization in the sinoatrial node.
PMID:27374078 SUPPORT Other
"L-type Cav 1.3 channels play a major role in the generation and regulation of sino-atrial pacemaker activity and atrioventricular conduction."
Confirms Cav1.3 as a major contributor to sinoatrial pacemaker activity, the current lost in SANDD.
PMID:27374078 SUPPORT Model Organism
"Global gene knockout of Cav1.3 channels induces a 60–70% reduction in the density of SAN"
Quantifies the magnitude of the sinoatrial L-type calcium current deficit caused by Cav1.3 loss in the mouse null.
Sinoatrial Node Pacemaker Dysfunction
Depressed pacemaker automaticity manifests as sinoatrial node dysfunction: the node fires slowly and its output becomes less regular from beat to beat. In the reported SANDD families this was detectable at rest in every affected individual, with slow but regular rhythms, narrow QRS complexes, and P waves that did not reliably precede the QRS. This is the bradyarrhythmic branch of the shared cardiac channelopathy module, with Cav1.3 substituted for the HCN4/SCN5A currents named in the generic module node.
cardiac pacemaker cell of sinoatrial node CL:1000477 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves cardiac pacemaker cell of sinoatrial node (CL:1000477). CL:1000477 is a cell type from the Cell Ontology.
cardiac conduction GO:0061337 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased cardiac conduction (GO:0061337). GO:0061337 is a biological process from the Gene Ontology. ↓ DECREASED regulation of heart rate GO:0002027 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal regulation of heart rate (GO:0002027). GO:0002027 is a biological process from the Gene Ontology. ⚠ ABNORMAL
sinoatrial node UBERON:0002351 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in sinoatrial node (UBERON:0002351). UBERON:0002351 is an anatomical location from the Uberon multi-species anatomy ontology.
Downstream
Resting Bradycardia with Increased Heart-Rate Variability Depressed and irregular sinoatrial automaticity produces a slow resting heart rate with greater beat-to-beat variability.
Show evidence (2 references)
PMID:21131953 SUPPORT Human Clinical
"All deaf subjects showed pronounced SAN dysfunction at rest."
Human clinical evidence that sinoatrial node dysfunction is present at rest in every affected individual of the founding families.
PMID:30498240 SUPPORT Human Clinical
"Hence, sinoartrial node dysfunction slows down the pacemaking activity of the heart"
States the causal step from sinoatrial node dysfunction to slowed pacemaking in the SANDD families. The source contains the typographical error "sinoartrial"; the snippet is quoted verbatim.
Atrioventricular Conduction Slowing
Cav1.3 is expressed in atrioventricular nodal as well as sinoatrial tissue, and its loss slows atrioventricular conduction in addition to depressing sinoatrial automaticity. Cav1.3-null mice show frank atrioventricular block. In humans the abstract-verifiable evidence is limited to the observation that P waves did not regularly precede the QRS complex in an affected individual, so whether high-grade atrioventricular block is part of the human SANDD phenotype is recorded here as an open question rather than asserted.
myocyte of atrioventricular node CL:1000410 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves myocyte of atrioventricular node (CL:1000410). CL:1000410 is a cell type from the Cell Ontology.
cardiac conduction GO:0061337 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased cardiac conduction (GO:0061337). GO:0061337 is a biological process from the Gene Ontology. ↓ DECREASED
atrioventricular node UBERON:0002352 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in atrioventricular node (UBERON:0002352). UBERON:0002352 is an anatomical location from the Uberon multi-species anatomy ontology.
Downstream
Exertion- and Stress-Triggered Syncope Atrioventricular conduction failure, where present, compounds the bradyarrhythmic reduction in cardiac output.
Show evidence (3 references)
PMID:27374078 SUPPORT Model Organism
"mice show bradycardia and atrioventricular block"
The Cav1.3-null mouse shows atrioventricular block alongside bradycardia, establishing the atrioventricular arm in the model organism.
PMID:27374078 SUPPORT Other
"L-type Cav 1.3 channels play a major role in the generation and regulation of sino-atrial pacemaker activity and atrioventricular conduction."
Supports Cav1.3 involvement in atrioventricular conduction. Graded PARTIAL because it states the physiological role rather than documenting atrioventricular block in human SANDD.
PMID:30498240 SUPPORT Human Clinical
"P wave did not regularly precede the QRS complex"
The only abstract-verifiable human observation suggesting atrioventricular dissociation in SANDD; graded PARTIAL because a single ECG description is not a diagnosis of atrioventricular block.
Resting Bradycardia with Increased Heart-Rate Variability
The clinical cardiac readout of SANDD is a pronounced resting bradycardia with increased beat-to-beat variability of heart rate. Reported rates are around 48 beats per minute at rest in an affected adolescent, against 60 beats per minute in a matched control, with a regular but slow rhythm and a narrow QRS complex. Chronotropic reserve is limited, so heart rate does not rise appropriately with exertion.
regulation of heart rate GO:0002027 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased regulation of heart rate (GO:0002027). GO:0002027 is a biological process from the Gene Ontology. ↓ DECREASED
Downstream
Exertion- and Stress-Triggered Syncope When demand rises with exertion or emotional stress, the bradycardic and chronotropically limited sinoatrial node cannot raise cardiac output sufficiently, leading to cerebral hypoperfusion and transient loss of consciousness.
Show evidence (2 references)
PMID:30498240 SUPPORT Human Clinical
"The recorded heart beat rate was 48 beats per minute (bpm) calculated from beat to beat R–R interval"
Quantifies the resting bradycardia and the beat-to-beat measurement in an affected individual.
PMID:30498240 SUPPORT Human Clinical
"We observed a slow heart beat rate along with severe-to-profound deafness in the SANDD-affected individuals"
Confirms the co-occurrence of bradycardia and deafness across the replication cohort.
Exertion- and Stress-Triggered Syncope
Episodic syncope, together with fatigue, dizziness, and exertional dyspnea, is the symptomatic endpoint of the cardiac arm. Episodes are characteristically provoked by enhanced physical activity or emotional stress, when the chronotropically limited node cannot meet demand. Note on conformance scope: the module node this maps to is named "Syncope and Sudden Cardiac Death", but only the syncope arm is documented in SANDD. No sudden cardiac death has been reported in the published families, and this entry makes no such claim.
Show evidence (2 references)
PMID:30498240 SUPPORT Human Clinical
"Additional features include fatigue, dizziness, and episodic syncope."
States the symptomatic endpoints of the cardiac arm of SANDD.
PMID:30498240 SUPPORT Human Clinical
"There were no obvious signs of vestibular dysfunction, but he did report the symptoms of fatigue, dizziness, and dyspnea."
Individual-level documentation of the low-output symptom complex (fatigue, dizziness, dyspnea) in an affected individual.
Loss of Cav1.3 Calcium Current at the Inner Hair Cell Ribbon Synapse
Cochlear inner hair cells convert sound-induced receptor potentials into graded glutamate release at specialized ribbon-type active zones. The calcium influx that triggers that release is carried almost entirely by Cav1.3 channels clustered at the ribbon, where only a small number of open channels impose the local nanodomain calcium signal on each release site. Non-conducting Cav1.3 therefore silences the presynaptic trigger for auditory transmitter release while leaving apical mechanotransduction itself intact.
cochlear inner hair cell CL:0000589 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves cochlear inner hair cell (CL:0000589). CL:0000589 is a cell type from the Cell Ontology.
neurotransmitter secretion GO:0007269 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased neurotransmitter secretion (GO:0007269). GO:0007269 is a biological process from the Gene Ontology. ↓ DECREASED
voltage-gated calcium channel activity GO:0005245 Gene Ontology (GO) Relation: this pathophysiological event involves this molecular function This pathophysiological event involves decreased voltage-gated calcium channel activity (GO:0005245). GO:0005245 is a molecular function from the Gene Ontology. ↓ DECREASED
cochlea UBERON:0001844 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in cochlea (UBERON:0001844). UBERON:0001844 is an anatomical location from the Uberon multi-species anatomy ontology.
Downstream
Arrested Inner Hair Cell Maturation Beyond acutely silencing release, loss of Cav1.3-mediated calcium entry removes the spontaneous pre-hearing calcium action potentials that drive the inner hair cell's developmental program.
Failure of Auditory Synaptic Transmission and Hair Cell Degeneration Without presynaptic calcium influx, inner hair cells cannot drive the auditory nerve; in the mouse null the hair cells subsequently degenerate.
Show evidence (3 references)
PMID:21131953 SUPPORT Other
"Ca(v)1.3 voltage-gated L-type calcium channels (LTCCs) translate sound-induced depolarization into neurotransmitter release in auditory hair cells and control diastolic depolarization in the mouse sinoatrial node (SAN)."
Establishes the auditory role of Cav1.3 as the coupler between sound-induced depolarization and transmitter release.
PMID:16354915 SUPPORT In Vitro
"We show by immunohistochemistry that the CaV1.3 Ca2+ channels are localized preferentially at the ribbon-type active zones of IHCs."
Localizes Cav1.3 to the inner hair cell ribbon active zone, the site of the presynaptic lesion in SANDD.
PMID:16354915 SUPPORT In Vitro
"Our findings suggest a Ca2+ channel-release site coupling in which few nearby CaV1.3 channels impose high nanodomain"
Shows that transmitter release at each active zone depends on a small number of Cav1.3 channels imposing a high local nanodomain calcium concentration, explaining why their loss is not tolerated.
Arrested Inner Hair Cell Maturation
Cav1.3 does more in the cochlea than trigger release moment to moment: the spontaneous calcium action potentials it carries before the onset of hearing drive the inner hair cell's own maturation. In the Cav1.3-null mouse those spikes are absent and the cell fails to complete its developmental program. It does not acquire functional large-conductance calcium-activated potassium (BK) channels, retains immature small-conductance (SK) channel expression, and abnormally retains efferent cholinergic innervation that should normally be withdrawn around the onset of hearing. The deafness of SANDD is therefore not only an acute transmission block but also a developmental arrest, which is one reason the hearing loss is congenital and non-progressive rather than late-onset. This arm is currently established only in the mouse.
cochlear inner hair cell CL:0000589 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves cochlear inner hair cell (CL:0000589). CL:0000589 is a cell type from the Cell Ontology.
inner ear receptor cell development GO:0060119 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal inner ear receptor cell development (GO:0060119). GO:0060119 is a biological process from the Gene Ontology. ⚠ ABNORMAL
cochlea UBERON:0001844 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in cochlea (UBERON:0001844). UBERON:0001844 is an anatomical location from the Uberon multi-species anatomy ontology.
Downstream
Failure of Auditory Synaptic Transmission and Hair Cell Degeneration An inner hair cell that never matures cannot sustain normal afferent signalling, compounding the acute release block and contributing to the later loss of synapses and cells.
Show evidence (3 references)
PMID:14645476 SUPPORT Model Organism
"Most strikingly, we observed a continued presence of efferent cholinergic synaptic transmission and a lack of functional large-conductance Ca2+-activated K+ channels up to 4 weeks after birth."
Documents the two hallmarks of the maturation arrest in the Cav1.3-null inner hair cell: retained efferent cholinergic innervation and failure to acquire functional BK channels.
PMID:14645476 SUPPORT Model Organism
"We conclude that CaV1.3 channels are essential for normal hair cell development and synaptic transmission."
States the dual developmental and synaptic requirement for Cav1.3 in the inner hair cell that this node captures.
PMID:16828974 SUPPORT Model Organism
"these data indicate that the Ca(V)1.3 channels are crucially involved in regulation of the expression of BK and SK channels."
Independent confirmation that Cav1.3 controls the BK/SK expression switch that marks inner hair cell maturation.
Failure of Auditory Synaptic Transmission and Hair Cell Degeneration
Loss of the inner hair cell L-type calcium current abolishes sound-evoked transmitter release to the auditory nerve. In the Cacna1d-null mouse this is accompanied by degeneration of both inner and outer hair cells, converting a presynaptic transmission failure into structural loss of the cochlear sensory epithelium. Direct human cochlear histopathology is not available for SANDD, so the degenerative component is currently inferred from the mouse model.
cochlear inner hair cell CL:0000589 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves cochlear inner hair cell (CL:0000589). CL:0000589 is a cell type from the Cell Ontology. cochlear outer hair cell CL:0000601 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves cochlear outer hair cell (CL:0000601). CL:0000601 is a cell type from the Cell Ontology.
sensory perception of sound GO:0007605 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased sensory perception of sound (GO:0007605). GO:0007605 is a biological process from the Gene Ontology. ↓ DECREASED
cochlea UBERON:0001844 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in cochlea (UBERON:0001844). UBERON:0001844 is an anatomical location from the Uberon multi-species anatomy ontology.
Downstream
Congenital Severe-to-Profound Sensorineural Deafness Absent auditory synaptic transmission, with subsequent hair cell loss, produces congenital non-progressive severe-to-profound hearing loss.
Show evidence (4 references)
PMID:10929716 SUPPORT Model Organism
"alpha1D-/-mice were deaf due to the complete absence of L-type currents in cochlear inner hair cells and degeneration of outer and inner hair cells."
The Cacna1d-null mouse shows loss of inner hair cell L-type current plus hair cell degeneration, the model-organism basis for the degenerative component of this node.
PMID:10929716 SUPPORT Model Organism
"We conclude that alpha1D can form LTCCs with negative activation thresholds essential for normal auditory function and control of cardiac pacemaker activity."
States the dual requirement for Cav1.3 in hearing and cardiac pacemaking that the human disorder recapitulates.
PMID:16828974 SUPPORT Model Organism
"Despite the near complete block of evoked afferent synaptic transmission, hair cell ribbon synapses were formed and remained preserved for at least 4 weeks after birth."
Establishes the temporal structure of the auditory arm in the model: the transmission block comes first and is not caused by failure to build the ribbon synapse, which is initially intact.
+ 1 more reference
Congenital Severe-to-Profound Sensorineural Deafness
The auditory endpoint is congenital sensorineural hearing loss in the severe (71-95 dB) to profound (>95 dB) range affecting all frequencies, present from birth and without evidence of accompanying vestibular dysfunction.
sensory perception of sound GO:0007605 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves absent sensory perception of sound (GO:0007605). GO:0007605 is a biological process from the Gene Ontology. ∅ ABSENT
cochlea UBERON:0001844 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in cochlea (UBERON:0001844). UBERON:0001844 is an anatomical location from the Uberon multi-species anatomy ontology.
Show evidence (1 reference)
PMID:30498240 SUPPORT Human Clinical
"Deafness was congenital and severe (71–95 dB) or profound (>95 dB) in all frequencies for all affected members of the SANDD families"
Audiometric characterization of the hearing loss across all reported SANDD families.
⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Pathograph: causal mechanism network for Sinoatrial Node Dysfunction and Deafness Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.
●

Phenotypes

8
Cardiovascular 1
Syncope OCCASIONAL HP:0001279 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Syncope (HP:0001279), qualified as temporality recurrent. HP:0001279 is a phenotype from the Human Phenotype Ontology.
Temporal: RECURRENT
Show evidence (1 reference)
PMID:30498240 SUPPORT Human Clinical
"Additional features include fatigue, dizziness, and episodic syncope."
Syncope is listed among the additional (that is, non-constant) features of SANDD, which maps to the OCCASIONAL band rather than to a constant feature.
Respiratory 1
Exertional Dyspnea HP:0002094 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Dyspnea (HP:0002094). HP:0002094 is a phenotype from the Human Phenotype Ontology.
Frequency omitted: dyspnea is documented in a single affected individual in the replication cohort, which is below the threshold at which a FrequencyEnum band can be justified.
Show evidence (1 reference)
PMID:30498240 SUPPORT Human Clinical
"There were no obvious signs of vestibular dysfunction, but he did report the symptoms of fatigue, dizziness, and dyspnea."
Single-individual documentation of dyspnea in the replication cohort.
Constitutional 1
Fatigue OCCASIONAL HP:0012378 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Fatigue (HP:0012378). HP:0012378 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:30498240 SUPPORT Human Clinical
"Additional features include fatigue, dizziness, and episodic syncope."
Fatigue is listed among the additional features of SANDD, mapping to the OCCASIONAL band.
Other 5
Congenital Severe-to-Profound Sensorineural Deafness VERY_FREQUENT Congenital sensorineural hearing impairment HP:0008527 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Congenital severe-to-profound sensorineural hearing impairment, annotated with Congenital sensorineural hearing impairment (HP:0008527), qualified as severity severe. HP:0008527 is a phenotype from the Human Phenotype Ontology.
Severity: SEVERE
Show evidence (2 references)
PMID:30498240 SUPPORT Human Clinical
"Deafness was congenital and severe (71–95 dB) or profound (>95 dB) in all frequencies for all affected members of the SANDD families"
Direct audiometric documentation of congenital severe-to-profound sensorineural deafness in all affected family members. The statement that it applies to all affected members supports the VERY_FREQUENT band.
PMID:21131953 SUPPORT Human Clinical
"in two consanguineous families with deafness"
Deafness is the ascertaining phenotype of the founding SANDD families.
Sinus Bradycardia VERY_FREQUENT HP:0001688 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Sinus bradycardia (HP:0001688). HP:0001688 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:21131953 SUPPORT Human Clinical
"All deaf subjects showed pronounced SAN dysfunction at rest."
Every deaf (that is, biallelic) subject in the founding families had resting sinoatrial node dysfunction, supporting the VERY_FREQUENT band.
PMID:30498240 SUPPORT Human Clinical
"The recorded heart beat rate was 48 beats per minute (bpm) calculated from beat to beat R–R interval"
Quantifies the resting bradycardia in an affected individual.
Abnormal Electrophysiology of Sinoatrial Node Origin VERY_FREQUENT HP:0011702 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Sinoatrial node dysfunction, annotated with Abnormal electrophysiology of sinoatrial node origin (HP:0011702). HP:0011702 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:21131953 SUPPORT Human Clinical
"All deaf subjects showed pronounced SAN dysfunction at rest."
Establishes resting sinoatrial node dysfunction as a constant feature in the founding families, supporting the VERY_FREQUENT band.
PMID:30498240 SUPPORT Human Clinical
"His ECG wave form clearly mark regular but slow rhythm, narrow QRS complex, and P wave did not regularly precede the QRS complex."
Describes the electrocardiographic signature of the sinoatrial node dysfunction.
Increased Heart Rate Variability HP:0031862 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Increased heart rate variability (HP:0031862). HP:0031862 is a phenotype from the Human Phenotype Ontology.
Frequency is intentionally omitted. The increased resting heart-rate variability is asserted in the Orphanet-derived MONDO definition of the disease but is not accompanied by a per-individual count or a quantitative HRV index in the primary literature, so no FrequencyEnum band can be justified.
Show evidence (1 reference)
PMID:30498240 SUPPORT Human Clinical
"The sinoatrial node (SAN) drives heart automaticity and continuously regulates heart rate."
Graded PARTIAL. The primary reports document sinoatrial node dysfunction and beat-to-beat R-R measurement but do not report a quantitative heart-rate-variability index; this snippet supports only the underlying claim that the affected node governs heart rate regulation.
Presyncopal Dizziness OCCASIONAL Presyncope HP:0031972 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Presyncope (HP:0031972). HP:0031972 is a phenotype from the Human Phenotype Ontology.
Term choice is deliberate. HPO has no free-standing "dizziness" term at this level of granularity; the obvious candidate, HP:0002321 Vertigo, is `is_a` HP:0001751 Abnormal vestibular function and would therefore assert exactly the vestibular involvement that the source explicitly excludes and that this entry's `gap_sandd_vestibular_sparing` discussion treats as an open question. HP:0031972 Presyncope is `is_a` HP:0011025 Abnormal cardiovascular system physiology and is defined as "a state of lightheadedness, muscular weakness, blurred vision, and feeling faint", "most often cardiovascular in cause", which matches the mechanism curated here. The sources say "dizziness" rather than "presyncope", so the mapping evidence is graded PARTIAL.
Show evidence (2 references)
PMID:30498240 SUPPORT Human Clinical
"There were no obvious signs of vestibular dysfunction, but he did report the symptoms of fatigue, dizziness, and dyspnea."
Documents dizziness in an affected individual while explicitly excluding vestibular dysfunction as its cause, which is what licenses binding this symptom to the cardiovascular Presyncope term rather than to Vertigo. Graded PARTIAL because the source records "dizziness" and does not itself use the word presyncope.
PMID:30498240 SUPPORT Human Clinical
"Additional features include fatigue, dizziness, and episodic syncope."
Places dizziness alongside frank syncope in the same symptom cluster, supporting a presyncopal rather than vestibular interpretation, and listing it among the additional (non-constant) features that map to the OCCASIONAL band.
🧬

Genetic Associations

2
CACNA1D
Gene: CACNA1D hgnc:1391 HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is CACNA1D (hgnc:1391). hgnc:1391 is a gene from the HUGO Gene Nomenclature Committee. relationship_type: CAUSATIVE
Show evidence (5 references)
PMID:21131953 SUPPORT Human Clinical
"We used positional cloning to identify a mutation in CACNA1D, which encodes the pore-forming α1 subunit of Ca(v)1.3 LTCCs, in two consanguineous families with deafness."
The gene-discovery study establishing CACNA1D as the SANDD gene.
PMID:21131953 SUPPORT In Vitro
"The insertion of a glycine residue in a highly conserved, alternatively spliced region near the channel pore resulted in nonconducting calcium channels that had abnormal voltage-dependent gating."
Heterologous expression demonstrates that the founder allele produces non-conducting Cav1.3 channels, establishing the loss-of-function mechanism.
PMID:30498240 SUPPORT Human Clinical
"We studied five Pakistani families with SANDD and characterized a new missense variant p.(A376V) in CACNA1D in one family, and further characterized the founder variant p.(G403_V404insG) in four additional pedigrees."
Independent replication of the gene-disease relationship and expansion of the allelic spectrum to a second, missense allele.
+ 2 more references
CACNA1D gain-of-function alleles (contrasting dominant disorders)
Gene: CACNA1D hgnc:1391 HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is CACNA1D (hgnc:1391). hgnc:1391 is a gene from the HUGO Gene Nomenclature Committee. relationship_type: UNKNOWN
Show evidence (4 references)
PMID:23913001 SUPPORT Human Clinical
"We also identified de novo germline mutations at identical positions in two children with a previously undescribed syndrome featuring primary aldosteronism and neuromuscular abnormalities."
Establishes the dominant, de novo gain-of-function arm of the CACNA1D allelic series, at the same residues (including Gly403) affected by the recessive SANDD insertion.
PMID:23913001 SUPPORT In Vitro
"Both alterations result in channel activation at less depolarized potentials; Gly403 alterations also impair channel inactivation."
Functional characterization showing that these variants are gain-of-function, the mechanistic mirror image of the non-conducting SANDD channels.
PMID:36430690 SUPPORT Human Clinical
"In addition, germline mutations in CACNA1D have been linked to neurodevelopmental syndromes including epileptic seizures, autism, intellectual disability and primary hyperaldosteronism."
Summarizes the dominant neurodevelopmental and endocrine arm of the CACNA1D allelic series that must not be merged with SANDD.
+ 1 more reference
💊

Medical Actions

4
Permanent Cardiac Pacemaker Implantation
Category: Therapeutic Action: pacemaker placementNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is pacemaker placement (NCIT:C80434). NCIT:C80434 is a clinical intervention from the NCI Thesaurus. Ontology label: Pacemaker Placement NCIT:C80434
Electronic pacing is the only established therapy for symptomatic sinus node dysfunction and is the mechanism-directed intervention for the cardiac arm of SANDD: it substitutes an artificial pacemaker for the failed Cav1.3-dependent sinoatrial automaticity. No SANDD-specific pacing series has been published, so the indication is extrapolated from general sick sinus syndrome management and the evidence below is graded accordingly. Device choice depends on whether atrioventricular conduction is also involved, which is an open question for this disorder.
Mechanism Target:
BYPASSES Sinoatrial Node Pacemaker Dysfunction — Pacing does not restore the Cav1.3 current; it bypasses the failed sinoatrial pacemaker by imposing an external rhythm.
Show evidence (1 reference)
PMID:27374078 SUPPORT Other
"Implantation of an electronic pacemaker constitutes the only available therapy for SSS."
A review of Cav1.3 channelopathies states that electronic pacing is the only available therapy for sick sinus syndrome. Graded PARTIAL because the statement is about sick sinus syndrome in general rather than a SANDD-specific outcome series.
Target Phenotypes: Sinus bradycardia HP:0001688 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Sinus bradycardia (HP:0001688). HP:0001688 is a phenotype from the Human Phenotype Ontology. Syncope HP:0001279 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Syncope (HP:0001279). HP:0001279 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:27374078 SUPPORT Other
"Implantation of an electronic pacemaker constitutes the only available therapy for SSS."
Supports pacing as the standard and only established therapy for the sick sinus phenotype; PARTIAL because it is not a SANDD-specific report.
Cochlear Implantation
Category: Therapeutic Action: cochlear implantationNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is cochlear implantation, annotated with Surgical Procedure (NCIT:C15329). NCIT:C15329 is a clinical intervention from the NCI Thesaurus. Ontology label: Surgical Procedure NCIT:C15329
Surgical cochlear implantation is the standard habilitation for congenital severe-to-profound sensorineural hearing loss and is the pragmatic option for the auditory arm of SANDD. No SANDD-specific implantation outcome data have been published; whether the underlying lesion is a pure presynaptic synaptopathy with a preserved spiral ganglion, which would predict good implant outcomes, is recorded as an open question in this entry's discussions.
Target Phenotypes: Congenital sensorineural hearing impairment HP:0008527 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Congenital sensorineural hearing impairment (HP:0008527). HP:0008527 is a phenotype from the Human Phenotype Ontology.
Genetic Counseling
Category: Counseling / Informational Action: genetic counselingNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is genetic counseling (NCIT:C15240). NCIT:C15240 is a clinical intervention from the NCI Thesaurus. Ontology label: Genetic Counseling NCIT:C15240
Autosomal recessive counseling for consanguineous families, including the 25% per-pregnancy recurrence risk for carrier couples and the availability of targeted testing for the founder p.Gly403_Val404insGly allele in families of Khyber Pakhtunkhwa origin. Heterozygous carriers are unaffected.
Show evidence (1 reference)
PMID:30498240 SUPPORT Human Clinical
"We show that affected individuals in the four families which segregate p.(G403_V404insG) share a 1.03 MB haplotype on 3p21.1 suggesting they share a common distant ancestor."
Supports the founder-allele basis for targeted carrier testing in this population. Graded PARTIAL because the paper documents the founder haplotype rather than counseling practice itself.
G-Protein-Gated Potassium (IKACh) Channel Inhibition
Category: Therapeutic Action: PharmacotherapyNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Pharmacotherapy (NCIT:C15986). NCIT:C15986 is a clinical intervention from the NCI Thesaurus. NCIT:C15986
An experimental, mechanism-directed strategy that does not replace the lost Cav1.3 current but removes an opposing hyperpolarizing current. Genetic or pharmacological ablation of the acetylcholine-activated inward-rectifier potassium current IKACh, for example with the GIRK pore blocker tertiapin-Q, rescues pacemaker activity in Cav1.3-null mice. This is preclinical only: no human SANDD trial exists, and the concept is included to record the therapeutic hypothesis attached to the mechanism, not to recommend treatment. Note the contrast with the dominant CACNA1D gain-of-function disorders, where Cav1.3 blockade is the rational strategy; blocking an already non-conducting channel would be pointless in SANDD.
Mechanism Target:
INHIBITS Sinoatrial Node Pacemaker Dysfunction — Blocking the opposing IKACh current shifts the net balance of sinoatrial currents toward depolarization, partially compensating for the absent Cav1.3 inward current.
Show evidence (1 reference)
PMID:27374078 SUPPORT Model Organism
"Work in our laboratory shows that targeting G protein-gated K+ (IKACh ) channels effectively rescues SSS of Cav 1.3-/- mice."
Demonstrates compensatory-channel targeting as a mechanism-directed rescue of the sick sinus phenotype in the Cav1.3-null model.
Show evidence (1 reference)
PMID:27374078 SUPPORT Model Organism
"This new concept of 'compensatory' ion channel targeting shines new light on the principles underlying the pacemaker mechanism and may open the way to new therapies for SSS."
Frames compensatory ion-channel targeting as a candidate future therapy for sinus node dysfunction, currently supported only in the mouse.
🔬

Diagnosis

6
Electrocardiography and ambulatory (Holter) rhythm monitoring (Resting bradycardia with sinoatrial node dysfunction was present in every affected individual across the reported families, so a normal resting ECG argues strongly against the diagnosis in a congenitally deaf proband.)
A resting 12-lead ECG establishes the sinoatrial abnormality: a slow but regular rhythm with a narrow QRS complex, P waves that do not regularly precede the QRS, and a normal QT interval (which is what separates SANDD at the bedside from Jervell and Lange-Nielsen syndrome). Ambulatory Holter recording quantifies the mean and minimum rate and captures pauses; Holter tracings from genotyped SANDD homozygotes are published. Exercise testing is used to demonstrate chronotropic incompetence when exertional symptoms are present.
electrocardiography NCIT:C38053 NCI Thesaurus (NCIT)
Show evidence (2 references)
PMID:30498240 SUPPORT Human Clinical
"His ECG wave form clearly mark regular but slow rhythm, narrow QRS complex, and P wave did not regularly precede the QRS complex."
Describes the diagnostic electrocardiographic signature recorded in an affected individual.
PMID:21131953 SUPPORT Human Clinical
"All deaf subjects showed pronounced SAN dysfunction at rest."
Supports resting electrocardiographic assessment as sufficient to detect the cardiac abnormality, which was present at rest in all affected individuals.
Ambulatory Holter monitoring
Continuous ambulatory ECG quantifies mean, maximum, and minimum heart rate over the day-night cycle and documents sinus pauses. Holter recordings from homozygous SANDD subjects have been published and reproduced in review figures.
Holter monitoring NCIT:C38064 NCI Thesaurus (NCIT)
Show evidence (1 reference)
PMID:27374078 SUPPORT Human Clinical
"sample Holter ECG recordings from individuals with normal heart rate (a), or from SANDD affected subjects, who were homozygous for the mutation"
Confirms that Holter monitoring has been applied to genotyped SANDD homozygotes and used to characterize their rhythm against controls.
Audiometric assessment (Congenital severe-to-profound sensorineural hearing loss across all frequencies, with clinically normal vestibular function.)
Pure-tone audiometry, supplemented in infancy by auditory brainstem response and otoacoustic emission testing, establishes the degree and configuration of the hearing loss. In SANDD it is congenital, bilateral, and severe (71-95 dB) to profound (>95 dB) across all frequencies, and formal vestibular assessment has not shown accompanying vestibular dysfunction.
audiometric testing NCIT:C38036 NCI Thesaurus (NCIT)
Show evidence (2 references)
PMID:30498240 SUPPORT Human Clinical
"Deafness was congenital and severe (71–95 dB) or profound (>95 dB) in all frequencies for all affected members of the SANDD families"
Reports the audiometric thresholds that define the auditory arm of the diagnosis.
PMID:30498240 SUPPORT Human Clinical
"There were no obvious signs of vestibular dysfunction"
Documents the negative vestibular finding that accompanies the audiometric result and helps separate SANDD from syndromic deafness with vestibular involvement.
CACNA1D molecular genetic testing
Molecular confirmation requires two pathogenic CACNA1D loss-of-function alleles in trans in an individual with a compatible phenotype. In families of Khyber Pakhtunkhwa origin, targeted testing for the founder p.(Gly403_Val404insGly) allele is the efficient first step; otherwise CACNA1D sequencing, a combined hearing-loss/arrhythmia panel, or exome sequencing is appropriate. Parental testing confirms phase and segregation. Interpretation must be direction-aware: heterozygous CACNA1D variants, particularly gain-of-function ones, cause mechanistically distinct dominant disorders and do not establish SANDD.
genetic testing NCIT:C15709 NCI Thesaurus (NCIT)
Show evidence (2 references)
PMID:30498240 SUPPORT Human Clinical
"We studied five Pakistani families with SANDD and characterized a new missense variant p.(A376V) in CACNA1D in one family, and further characterized the founder variant p.(G403_V404insG) in four additional pedigrees."
Documents the two CACNA1D alleles that molecular testing is looking for, including the recurrent founder variant.
PMID:36430690 SUPPORT Human Clinical
"So far, homozygous loss of function mutations in CACNA1D encoding the Cav1.3 α1-subunit are described in congenital sinus node dysfunction and deafness."
States the zygosity and functional-direction requirement that makes a molecular diagnosis of SANDD, as opposed to one of the heterozygous CACNA1D disorders.
Cardiac screening of individuals with congenital deafness
Because deafness is the ascertaining feature and the bradycardia may be clinically silent, electrocardiographic screening of individuals with congenital deafness in the founder region is recommended, so that affected individuals enter cardiac follow-up before symptomatic sinus node failure develops. The same logic underlies the long-standing practice of screening congenitally deaf children for the QT prolongation of Jervell and Lange-Nielsen syndrome.
disease screening NCIT:C15419 NCI Thesaurus (NCIT)
Relocated from `treatments:` to `diagnosis:` because this is a case-finding procedure that detects the sinoatrial phenotype rather than a therapeutic action that treats it.
Show evidence (1 reference)
PMID:30498240 SUPPORT Human Clinical
"Therefore, screening patients with congenital deafness for SAN dysfunction in this province could ensure adequate follow-up and prevent cardiac failure associated with SAN."
The replication study explicitly recommends screening congenitally deaf individuals in the founder region for sinoatrial node dysfunction.
Echocardiography to exclude structural heart disease
Echocardiography is used to confirm that the heart is structurally normal, which is a defining condition of the inherited-channelopathy framing that places SANDD in the cardiac ion-channel module, and to exclude structural or cardiomyopathic causes of bradyarrhythmia. It also separates SANDD from HCN4-related bradycardia with left ventricular noncompaction and from LMNA-related conduction disease with cardiomyopathy.
echocardiography NCIT:C16525 NCI Thesaurus (NCIT)
No SANDD-specific imaging series has been published, so no evidence item is attached. This entry lists echocardiography as the standard exclusion step for structural causes of bradyarrhythmia rather than citing a stretched source; the project's evidence policy prefers an unevidenced description to a fabricated or over-reaching citation.
📊

Prevalence

2
Worldwide
Cases In Literature Ultra Rare
SANDD is known from a very small number of consanguineous Pakistani families: two in the founding report and five in the subsequent replication study. No population-based prevalence estimate exists. The Orphanet epidemiology record for ORPHA:324321 was not consulted because the local Orphadata refresh is currently broken (checksum failure), so only the qualitative ULTRA_RARE band is asserted here.
Show evidence (2 references)
PMID:30498240 SUPPORT Human Clinical
"Sinoatrial node dysfunction and deafness (SANDD) syndrome is rare and characterized by a low heart beat and severe-to-profound deafness."
Establishes the disorder as rare; combined with the fact that the total published cohort is a handful of families, this supports the ULTRA_RARE qualitative band.
PMID:32601767 SUPPORT Other
"Ca2+ channel channelopathies specifically affecting cardiac automaticity are considered rare."
Independent review characterizes this class of calcium-channel automaticity channelopathies, of which SANDD is the exemplar, as rare.
Khyber Pakhtunkhwa province, Pakistan
Unknown Unknown
The p.Gly403_Val404insGly founder allele has so far been observed only in families from the Khyber Pakhtunkhwa (KPK) province of Pakistan, giving a locally enriched but unquantified burden and motivating targeted cardiac screening of congenitally deaf individuals in that region.
Show evidence (1 reference)
PMID:30498240 SUPPORT Human Clinical
"This study is of clinical importance as the CACNA1D founder variant is only observed in families from the Khyber Pakhtunkhwa (KPK) province, in Pakistan."
Documents the geographic restriction of the founder allele without giving a numeric rate.
{ }

Source YAML

click to show 
name: Sinoatrial Node Dysfunction and Deafness
creation_date: "2026-08-01T00:00:00Z"
description: >-
  Sinoatrial node dysfunction and deafness (SANDD) is an ultra-rare autosomal
  recessive human channelopathy caused by biallelic loss-of-function variants in
  CACNA1D, which encodes the pore-forming alpha-1D subunit of the Cav1.3 L-type
  voltage-gated calcium channel. It is mechanistically elegant because a single
  channel lesion produces two clinically unrelated manifestations in two
  tissues: Cav1.3 carries the low-threshold, slowly inactivating L-type calcium
  current that contributes to diastolic depolarization in sinoatrial node
  pacemaker cells, and the same channel supplies the calcium influx that
  triggers glutamate release at the cochlear inner hair cell ribbon synapse.
  Affected individuals therefore present with congenital severe-to-profound
  sensorineural deafness (with no evidence of vestibular dysfunction) together
  with pronounced resting bradycardia, increased resting heart-rate variability,
  and episodic syncope that may be triggered by exertion or emotional stress.
  The disorder was defined in consanguineous Pakistani families, in which a
  founder in-frame glycine insertion near the channel pore
  (c.1208_1209insGGG, p.Gly403_Val404insGly) yields non-conducting Cav1.3
  channels; the human phenotype closely recapitulates the Cacna1d-null mouse.
  Heterozygous carriers of the SANDD alleles are unaffected, which distinguishes
  SANDD from the dominant CACNA1D gain-of-function disorders (primary
  aldosteronism with seizures and neurologic abnormalities, autism spectrum
  disorder, and a sinus-node-dysfunction/epilepsy syndrome) that arise at the
  same locus.
category: Mendelian
disease_term:
  preferred_term: sinoatrial node dysfunction and deafness
  term:
    id: MONDO:0013960
    label: sinoatrial node dysfunction and deafness
synonyms:
- SANDD
- SANDD syndrome
- sinus node dysfunction and deafness
- CACNA1D-related sinoatrial node dysfunction and deafness
- Cav1.3 channelopathy
parents:
- Cardiac Arrhythmia
- Channelopathy
classifications:
  harrisons_chapter:
  - classification_value: CARDIOVASCULAR
    evidence:
    - reference: PMID:21131953
      reference_title: "Loss of Ca(v)1.3 (CACNA1D) function in a human channelopathy with bradycardia and congenital deafness."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "All deaf subjects showed pronounced SAN dysfunction at rest."
      explanation: >-
        The cardiac arm (sinoatrial node dysfunction with bradycardia) places
        SANDD in the cardiovascular Part alongside the other inherited
        arrhythmia syndromes.
  - classification_value: NEUROLOGIC
    evidence:
    - reference: PMID:21131953
      reference_title: "Loss of Ca(v)1.3 (CACNA1D) function in a human channelopathy with bradycardia and congenital deafness."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "in two consanguineous families with deafness"
      explanation: >-
        The auditory arm is a disorder of special-sense (cochlear) function and
        is conventionally catalogued with the neurologic/sensory disorders.
  - classification_value: GENETICS_ENVIRONMENT_DISEASE
    evidence:
    - reference: PMID:30498240
      reference_title: "Identification of CACNA1D variants associated with sinoatrial node dysfunction and deafness in additional Pakistani families reveals a clinical significance."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "In conclusion, we identified new and known variants in CACNA1D in five Pakistani families with SANDD."
      explanation: >-
        SANDD is a Mendelian single-gene disorder defined by segregating
        CACNA1D variants, so it also belongs to the genetics Part.
  channelopathy_category:
    classification_value: cardiac channelopathy
    notes: >-
      SANDD is simultaneously a cardiac channelopathy (loss of the Cav1.3
      L-type calcium current in sinoatrial pacemaker cells) and a cochlear
      synaptopathy (loss of the same current at the inner hair cell ribbon
      synapse). ChannelopathyOrganSystemEnum is single-valued in the schema, so
      only the cardiac assignment can be recorded here; the auditory arm is
      modeled explicitly in the pathophysiology nodes "Loss of Cav1.3 Calcium
      Current at the Inner Hair Cell Ribbon Synapse" and "Failure of Auditory
      Synaptic Transmission and Hair Cell Degeneration".
    evidence:
    - reference: PMID:21131953
      reference_title: "Loss of Ca(v)1.3 (CACNA1D) function in a human channelopathy with bradycardia and congenital deafness."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "We describe a human channelopathy (termed SANDD syndrome, sinoatrial node dysfunction and deafness) with a cardiac and auditory phenotype that closely resembles that of Cacna1d(-/-) mice."
      explanation: >-
        The founding paper explicitly frames SANDD as a human channelopathy with
        both a cardiac and an auditory phenotype. Graded PARTIAL because this
        single-valued slot can only record the cardiac assignment.
notes: >-
  IDENTITY / NEC NOTE. The causal gene of MONDO:0013960 (OMIM 614896) is
  CACNA1D, encoding Cav1.3, not HCN4. The curation issue that requested this
  entry (monarch-initiative/dismech#7716) described SANDD as "biallelic loss of
  the HCN4 pacemaker channel"; the mandatory NEC preflight against the MONDO
  record (which asserts RO:0004003 to HGNC:1391 CACNA1D) and against the
  founding literature (PMID:21131953, which coined the SANDD name for the
  CACNA1D channelopathy; and PMID:32601767, which ties CACNA1D to OMIM 614896
  by number) showed that attribution to be incorrect. HCN4 is the
  hyperpolarization-activated "funny current" gene; its variants cause
  autosomal dominant sick sinus syndrome / bradycardia with or without left
  ventricular noncompaction WITHOUT deafness, and that entity is curated
  separately as Familial Sick Sinus Syndrome. This entry is curated against the
  verified CACNA1D identity.

  DIFFERENTIAL. The closest phenotypic mimic is Jervell and Lange-Nielsen
  syndrome, which also pairs congenital profound deafness with a cardiac
  channelopathy but is caused by biallelic KCNQ1/KCNE1 variants and produces QT
  prolongation and ventricular tachyarrhythmia rather than bradycardia. The
  founding SANDD paper contrasts the two explicitly. SANDD is distinguished at
  the bedside by a slow, regular rhythm with a narrow QRS and a normal QT.
  Other differentials are HCN4-related sinus node disease and SCN5A-related
  conduction disease (neither with deafness), and the dominant CACNA1D
  neurodevelopmental/endocrine channelopathies (no deafness, plus neurologic or
  endocrine features).

  ABSENCE OF VESTIBULAR INVOLVEMENT. Both the MONDO definition and the
  published families emphasize that vestibular function is spared despite
  profound cochlear deafness. This is a mechanistically informative negative
  finding (vestibular hair cells appear less dependent on Cav1.3 than cochlear
  inner hair cells) and is recorded here as a discussion/knowledge gap rather
  than as a phenotype assertion.

  ATRIOVENTRICULAR CONDUCTION. Reviews of the Cav1.3 channelopathies describe
  atrioventricular conduction disease as part of the spectrum, and the
  Cav1.3-null mouse clearly shows atrioventricular block. In humans, the only
  abstract-verifiable observation is that P waves do not regularly precede the
  QRS complex in an affected individual. Human high-grade atrioventricular
  block is therefore modeled here only as a model-organism-supported mechanism
  plus an open knowledge gap, not as an established human phenotype with a
  frequency band.

  MODULE CONFORMANCE SCOPE. This entry declares conforms_to against
  cardiac_ion_channel_repolarization for the cardiac arm only. It deliberately
  does NOT declare conformance to sensorineural_hair_cell_loss: that module's
  central effector node is "Hair Cell Mechanotransduction Failure and Death",
  framed around oxidative/ototoxic injury causing mechanotransduction failure,
  whereas the SANDD lesion is a presynaptic ribbon-synapse Ca2+-influx failure
  downstream of intact mechanotransduction, with hair cell degeneration
  demonstrated only in the mouse null. Asserting that conformance would
  misstate the mechanism.

  GROUPING CANDIDACY. SANDD satisfies the NECESSARY_AND_SUFFICIENT criteria of
  the Inherited_Arrhythmia_Syndromes grouping (conforms to the cardiac
  ion-channel module in a structurally normal heart, and does not conform to
  cardiomyopathy_maladaptive_remodeling), so `just check-groupings` should
  surface it as a candidate member alongside Familial Sick Sinus Syndrome. The
  grouping file is intentionally not edited by this PR.
mappings:
  mondo_mappings:
  - term:
      id: MONDO:0013960
      label: sinoatrial node dysfunction and deafness
    mapping_predicate: skos:exactMatch
    mapping_source: MONDO
    mapping_justification: >-
      MONDO:0013960 is the primary disease term for this entry, cross-referenced
      to OMIM:614896 and Orphanet:324321, with CACNA1D (HGNC:1391) asserted as
      the causal gene.
inheritance:
- name: Autosomal Recessive
  description: >-
    SANDD is inherited in an autosomal recessive manner. All reported families
    are consanguineous Pakistani pedigrees in which affected individuals are
    homozygous for a CACNA1D loss-of-function allele; heterozygous carriers,
    including the obligate-carrier parents, are clinically unaffected with
    respect to both hearing and heart rate. Four of the five families in the
    replication cohort share a 1.03 Mb haplotype around the founder
    p.Gly403_Val404insGly allele, indicating a common distant ancestor. Carrier
    couples face the standard 25% per-pregnancy recurrence risk.
  inheritance_term:
    preferred_term: Autosomal recessive inheritance
    term:
      id: HP:0000007
      label: Autosomal recessive inheritance
  evidence:
  - reference: PMID:21131953
    reference_title: "Loss of Ca(v)1.3 (CACNA1D) function in a human channelopathy with bradycardia and congenital deafness."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We used positional cloning to identify a mutation in CACNA1D, which encodes the pore-forming α1 subunit of Ca(v)1.3 LTCCs, in two consanguineous families with deafness."
    explanation: >-
      Positional cloning in consanguineous pedigrees establishes the recessive
      architecture of the disorder.
  - reference: PMID:30498240
    reference_title: "Identification of CACNA1D variants associated with sinoatrial node dysfunction and deafness in additional Pakistani families reveals a clinical significance."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We show that affected individuals in the four families which segregate p.(G403_V404insG) share a 1.03 MB haplotype on 3p21.1 suggesting they share a common distant ancestor."
    explanation: >-
      Shared-haplotype analysis across four additional consanguineous pedigrees
      confirms recessive segregation of a founder allele.
  - reference: PMID:36430690
    reference_title: "Whole Exome Sequencing Identifies a Heterozygous Variant in the Cav1.3 Gene CACNA1D Associated with Familial Sinus Node Dysfunction and Focal Idiopathic Epilepsy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "So far, homozygous loss of function mutations in CACNA1D encoding the Cav1.3 α1-subunit are described in congenital sinus node dysfunction and deafness."
    explanation: >-
      Independent confirmation that the SANDD phenotype requires homozygous
      (biallelic) loss of function, distinguishing it from the heterozygous
      CACNA1D presentations.
prevalence:
- population: Worldwide
  measure_type: CASES_IN_LITERATURE
  prevalence_class: ULTRA_RARE
  notes: >-
    SANDD is known from a very small number of consanguineous Pakistani
    families: two in the founding report and five in the subsequent replication
    study. No population-based prevalence estimate exists. The Orphanet
    epidemiology record for ORPHA:324321 was not consulted because the local
    Orphadata refresh is currently broken (checksum failure), so only the
    qualitative ULTRA_RARE band is asserted here.
  evidence:
  - reference: PMID:30498240
    reference_title: "Identification of CACNA1D variants associated with sinoatrial node dysfunction and deafness in additional Pakistani families reveals a clinical significance."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Sinoatrial node dysfunction and deafness (SANDD) syndrome is rare and characterized by a low heart beat and severe-to-profound deafness."
    explanation: >-
      Establishes the disorder as rare; combined with the fact that the total
      published cohort is a handful of families, this supports the ULTRA_RARE
      qualitative band.
  - reference: PMID:32601767
    reference_title: "Channelopathies of voltage-gated L-type Cav1.3/α(1D) and T-type Cav3.1/α(1G) Ca(2+) channels in dysfunction of heart automaticity."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Ca2+ channel channelopathies specifically affecting cardiac automaticity are considered rare."
    explanation: >-
      Independent review characterizes this class of calcium-channel
      automaticity channelopathies, of which SANDD is the exemplar, as rare.
- population: Khyber Pakhtunkhwa province, Pakistan
  measure_type: UNKNOWN
  prevalence_class: UNKNOWN
  notes: >-
    The p.Gly403_Val404insGly founder allele has so far been observed only in
    families from the Khyber Pakhtunkhwa (KPK) province of Pakistan, giving a
    locally enriched but unquantified burden and motivating targeted cardiac
    screening of congenitally deaf individuals in that region.
  evidence:
  - reference: PMID:30498240
    reference_title: "Identification of CACNA1D variants associated with sinoatrial node dysfunction and deafness in additional Pakistani families reveals a clinical significance."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "This study is of clinical importance as the CACNA1D founder variant is only observed in families from the Khyber Pakhtunkhwa (KPK) province, in Pakistan."
    explanation: >-
      Documents the geographic restriction of the founder allele without giving
      a numeric rate.
genetic:
- name: CACNA1D
  notes: >-
    CACNA1D (3p21.1) encodes the pore-forming alpha-1D subunit of the Cav1.3
    L-type voltage-gated calcium channel. Cav1.3 differs from its close
    paralogue Cav1.2 in activating at unusually negative membrane potentials
    and inactivating slowly, which is what makes it suitable both for
    contributing inward current during sinoatrial diastolic depolarization and
    for sustaining graded transmitter release at the cochlear inner hair cell
    ribbon synapse. Two SANDD alleles are published: the founder in-frame
    insertion c.1208_1209insGGG, p.(Gly403_Val404insGly) (also written
    p.Gly403dup), which places an extra glycine in the alternatively spliced
    IS6 region near the channel pore and yields channels that reach the plasma
    membrane but conduct no calcium current; and the missense c.1127C>T,
    p.(Ala376Val). ClinVar classifications and gnomAD allele counts were not
    verified for this entry and should be checked against a specified
    transcript before downstream use.

    ALLELIC SERIES. The same locus produces mechanistically opposite dominant
    disorders. De novo heterozygous GAIN-of-function variants at Gly403 and
    Ile770 cause a syndrome of primary aldosteronism with seizures and
    neurologic abnormalities (PASNA), and further de novo gain-of-function
    variants are found in autism spectrum disorder; a heterozygous
    isoform-dependent p.Arg930His variant produces familial sinus node
    dysfunction with idiopathic epilepsy and ADHD. That the recessive SANDD
    glycine insertion and the dominant PASNA substitutions both fall at Gly403
    makes CACNA1D an unusually clean natural experiment in channel
    loss-of-function versus gain-of-function.
  gene_term:
    preferred_term: CACNA1D
    term:
      id: hgnc:1391
      label: CACNA1D
  relationship_type: CAUSATIVE
  evidence:
  - reference: PMID:21131953
    reference_title: "Loss of Ca(v)1.3 (CACNA1D) function in a human channelopathy with bradycardia and congenital deafness."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We used positional cloning to identify a mutation in CACNA1D, which encodes the pore-forming α1 subunit of Ca(v)1.3 LTCCs, in two consanguineous families with deafness."
    explanation: >-
      The gene-discovery study establishing CACNA1D as the SANDD gene.
  - reference: PMID:21131953
    reference_title: "Loss of Ca(v)1.3 (CACNA1D) function in a human channelopathy with bradycardia and congenital deafness."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "The insertion of a glycine residue in a highly conserved, alternatively spliced region near the channel pore resulted in nonconducting calcium channels that had abnormal voltage-dependent gating."
    explanation: >-
      Heterologous expression demonstrates that the founder allele produces
      non-conducting Cav1.3 channels, establishing the loss-of-function
      mechanism.
  - reference: PMID:30498240
    reference_title: "Identification of CACNA1D variants associated with sinoatrial node dysfunction and deafness in additional Pakistani families reveals a clinical significance."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We studied five Pakistani families with SANDD and characterized a new missense variant p.(A376V) in CACNA1D in one family, and further characterized the founder variant p.(G403_V404insG) in four additional pedigrees."
    explanation: >-
      Independent replication of the gene-disease relationship and expansion of
      the allelic spectrum to a second, missense allele.
  - reference: PMID:32601767
    reference_title: "Channelopathies of voltage-gated L-type Cav1.3/α(1D) and T-type Cav3.1/α(1G) Ca(2+) channels in dysfunction of heart automaticity."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Recent research on familial disease has identified mutations in the Cav1.3-encoding CACNA1D gene that underlie congenital sinus node dysfunction and deafness (OMIM # 614896)."
    explanation: >-
      Review evidence that explicitly ties CACNA1D to OMIM 614896, the OMIM
      identifier cross-referenced by MONDO:0013960. This is the anchor citation
      for the NEC identity check recorded in the entry notes.
  - reference: PMID:23219801
    reference_title: "What can naturally occurring mutations tell us about Ca(v)1.x channel function?"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "mutations in Ca(v)1.3 α1 are linked to sinoatrial node dysfunction and deafness"
    explanation: >-
      Review of the Cav1.x channelopathies independently assigns SANDD to
      Cav1.3/CACNA1D.
- name: CACNA1D gain-of-function alleles (contrasting dominant disorders)
  notes: >-
    Recorded to make the allelic contrast machine-visible, not because these
    variants cause SANDD. Heterozygous de novo GAIN-of-function CACNA1D
    variants produce dominant disorders that share no phenotypic overlap with
    SANDD: primary aldosteronism with seizures and neurologic abnormalities
    (PASNA), autism spectrum disorder, and a familial sinus node
    dysfunction/epilepsy/ADHD syndrome caused by an isoform-dependent
    p.Arg930His variant that is gain-of-function in the short brain isoform and
    loss-of-function in the long cardiac isoform. Deafness is not a feature of
    any of these dominant presentations. Note the therapeutic corollary: Cav1.3
    blockers such as isradipine are being explored for the gain-of-function
    disorders, and blocking an already non-conducting channel is not a rational
    strategy in SANDD.
  gene_term:
    preferred_term: CACNA1D
    term:
      id: hgnc:1391
      label: CACNA1D
  relationship_type: UNKNOWN
  evidence:
  - reference: PMID:23913001
    reference_title: "Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We also identified de novo germline mutations at identical positions in two children with a previously undescribed syndrome featuring primary aldosteronism and neuromuscular abnormalities."
    explanation: >-
      Establishes the dominant, de novo gain-of-function arm of the CACNA1D
      allelic series, at the same residues (including Gly403) affected by the
      recessive SANDD insertion.
  - reference: PMID:23913001
    reference_title: "Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "Both alterations result in channel activation at less depolarized potentials; Gly403 alterations also impair channel inactivation."
    explanation: >-
      Functional characterization showing that these variants are
      gain-of-function, the mechanistic mirror image of the non-conducting
      SANDD channels.
  - reference: PMID:36430690
    reference_title: "Whole Exome Sequencing Identifies a Heterozygous Variant in the Cav1.3 Gene CACNA1D Associated with Familial Sinus Node Dysfunction and Focal Idiopathic Epilepsy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In addition, germline mutations in CACNA1D have been linked to neurodevelopmental syndromes including epileptic seizures, autism, intellectual disability and primary hyperaldosteronism."
    explanation: >-
      Summarizes the dominant neurodevelopmental and endocrine arm of the
      CACNA1D allelic series that must not be merged with SANDD.
  - reference: PMID:36430690
    reference_title: "Whole Exome Sequencing Identifies a Heterozygous Variant in the Cav1.3 Gene CACNA1D Associated with Familial Sinus Node Dysfunction and Focal Idiopathic Epilepsy."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "a gain of ion channel function was observed in the brain-specific short CACNA1D isoform (Cav1.3S), whereas a loss of ion channel function was seen in the long (Cav1.3L) isoform."
    explanation: >-
      Documents the isoform-dependent, dominantly inherited variant that causes
      sinus node dysfunction WITHOUT deafness, sharpening the contrast with
      biallelic SANDD.
pathophysiology:
- name: Biallelic CACNA1D Loss of Function
  conforms_to: "cardiac_ion_channel_repolarization#Cardiac Ion-Channel or Calcium-Handling Variant"
  role: trigger
  biological_scale: MOLECULAR
  description: >-
    Homozygous CACNA1D loss-of-function variants abolish conduction through the
    Cav1.3 L-type voltage-gated calcium channel. The founder allele inserts an
    extra glycine into a highly conserved, alternatively spliced segment near
    the channel pore and yields channels that reach the membrane but do not
    conduct calcium and show abnormal voltage-dependent gating. Because Cav1.3
    is the low-voltage-activated, slowly inactivating member of the L-type
    family, its loss cannot be compensated by the co-expressed Cav1.2 channel
    in either of the two tissues that depend on it.
  genes:
  - preferred_term: CACNA1D
    term:
      id: hgnc:1391
      label: CACNA1D
  molecular_functions:
  - preferred_term: voltage-gated calcium channel activity
    term:
      id: GO:0005245
      label: voltage-gated calcium channel activity
    modifier: DECREASED
  biological_processes:
  - preferred_term: calcium ion transmembrane transport
    term:
      id: GO:0070588
      label: calcium ion transmembrane transport
    modifier: DECREASED
  evidence:
  - reference: PMID:21131953
    reference_title: "Loss of Ca(v)1.3 (CACNA1D) function in a human channelopathy with bradycardia and congenital deafness."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "The insertion of a glycine residue in a highly conserved, alternatively spliced region near the channel pore resulted in nonconducting calcium channels that had abnormal voltage-dependent gating."
    explanation: >-
      Direct functional evidence that the SANDD founder allele produces
      non-conducting Cav1.3 channels.
  - reference: PMID:27374078
    reference_title: "Rescuing cardiac automaticity in L-type Cav1.3 channelopathies and beyond."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Mutation in the CACNA1D gene encoding Cav 1.3 channels induces loss-of-function in channel activity and underlies the sino-atrial node dysfunction and deafness syndrome (SANDD)."
    explanation: >-
      Review confirms channel loss of function as the proximate trigger of
      SANDD.
  downstream:
  - target: Loss of Cav1.3 Calcium Current in Sinoatrial Pacemaker Cells
    description: >-
      Non-conducting Cav1.3 channels remove the low-threshold L-type calcium
      current that contributes inward charge during the diastolic
      depolarization of sinoatrial node pacemaker cells.
    evidence:
    - reference: PMID:27374078
      reference_title: "Rescuing cardiac automaticity in L-type Cav1.3 channelopathies and beyond."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "L-type Cav 1.3 channels play a major role in the generation and regulation of sino-atrial pacemaker activity and atrioventricular conduction."
      explanation: >-
        Establishes that the channel lost in SANDD is the one that carries the
        sinoatrial pacemaker current, which is what makes this causal edge hold.
  - target: Loss of Cav1.3 Calcium Current at the Inner Hair Cell Ribbon Synapse
    description: >-
      The same non-conducting channels remove the presynaptic calcium influx on
      which glutamate release at the cochlear inner hair cell ribbon synapse
      depends.
    evidence:
    - reference: PMID:21131953
      reference_title: "Loss of Ca(v)1.3 (CACNA1D) function in a human channelopathy with bradycardia and congenital deafness."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "Ca(v)1.3 voltage-gated L-type calcium channels (LTCCs) translate sound-induced depolarization into neurotransmitter release in auditory hair cells"
      explanation: >-
        Establishes that the same channel carries the presynaptic auditory
        calcium influx, which is what makes the second branch of this fork hold.
- name: Loss of Cav1.3 Calcium Current in Sinoatrial Pacemaker Cells
  role: central_effector
  biological_scale: CELLULAR
  description: >-
    In sinoatrial node pacemaker cells the slow diastolic depolarization that
    sets the intrinsic firing rate is built from several inward currents,
    including the Cav1.3 L-type calcium current, which activates at unusually
    negative potentials (close to -55 mV under adrenergic activation). Loss of
    that current slows the rate of diastolic depolarization and delays the time
    at which the pacemaker cell reaches threshold, reducing intrinsic
    automaticity. In the Cav1.3-null mouse the sinoatrial L-type current density
    falls by 60-70%, quantifying the size of the lesion.
  cell_types:
  - preferred_term: cardiac pacemaker cell of sinoatrial node
    term:
      id: CL:1000477
      label: cardiac pacemaker cell of sinoatrial node
  molecular_functions:
  - preferred_term: voltage-gated calcium channel activity involved SA node cell action potential
    term:
      id: GO:0086059
      label: voltage-gated calcium channel activity involved SA node cell action potential
    modifier: DECREASED
  biological_processes:
  - preferred_term: membrane depolarization during SA node cell action potential
    term:
      id: GO:0086046
      label: membrane depolarization during SA node cell action potential
    modifier: DECREASED
  locations:
  - preferred_term: sinoatrial node
    term:
      id: UBERON:0002351
      label: sinoatrial node
  evidence:
  - reference: PMID:21131953
    reference_title: "Loss of Ca(v)1.3 (CACNA1D) function in a human channelopathy with bradycardia and congenital deafness."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Ca(v)1.3 voltage-gated L-type calcium channels (LTCCs) translate sound-induced depolarization into neurotransmitter release in auditory hair cells and control diastolic depolarization in the mouse sinoatrial node (SAN)."
    explanation: >-
      States the two tissue-specific roles of Cav1.3, including control of
      diastolic depolarization in the sinoatrial node.
  - reference: PMID:27374078
    reference_title: "Rescuing cardiac automaticity in L-type Cav1.3 channelopathies and beyond."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "L-type Cav 1.3 channels play a major role in the generation and regulation of sino-atrial pacemaker activity and atrioventricular conduction."
    explanation: >-
      Confirms Cav1.3 as a major contributor to sinoatrial pacemaker activity,
      the current lost in SANDD.
  - reference: PMID:27374078
    reference_title: "Rescuing cardiac automaticity in L-type Cav1.3 channelopathies and beyond."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Global gene knockout of Cav1.3 channels induces a 60–70% reduction in the density of SAN"
    explanation: >-
      Quantifies the magnitude of the sinoatrial L-type calcium current deficit
      caused by Cav1.3 loss in the mouse null.
  downstream:
  - target: Sinoatrial Node Pacemaker Dysfunction
    description: >-
      Slowed diastolic depolarization in individual pacemaker cells translates
      into depressed automaticity of the sinoatrial node as a whole.
    evidence:
    - reference: PMID:10929716
      reference_title: "Congenital deafness and sinoatrial node dysfunction in mice lacking class D L-type Ca2+ channels."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "Electrocardiogram recordings revealed sinoatrial node dysfunction (bradycardia and arrhythmia) in alpha1D-/- mice."
      explanation: >-
        Genetic ablation of the same channel produces measurable sinoatrial node
        dysfunction in vivo, demonstrating that loss of the cellular current
        does propagate to nodal-level dysfunction.
  - target: Atrioventricular Conduction Slowing
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - loss of the same Cav1.3 current in atrioventricular nodal cells
    description: >-
      Cav1.3 is expressed in atrioventricular as well as sinoatrial nodal
      tissue, so the same current loss slows atrioventricular conduction.
- name: Sinoatrial Node Pacemaker Dysfunction
  conforms_to: "cardiac_ion_channel_repolarization#Sinoatrial Node Pacemaker Dysfunction"
  role: effector
  biological_scale: TISSUE
  description: >-
    Depressed pacemaker automaticity manifests as sinoatrial node dysfunction:
    the node fires slowly and its output becomes less regular from beat to
    beat. In the reported SANDD families this was detectable at rest in every
    affected individual, with slow but regular rhythms, narrow QRS complexes,
    and P waves that did not reliably precede the QRS. This is the
    bradyarrhythmic branch of the shared cardiac channelopathy module, with
    Cav1.3 substituted for the HCN4/SCN5A currents named in the generic module
    node.
  cell_types:
  - preferred_term: cardiac pacemaker cell of sinoatrial node
    term:
      id: CL:1000477
      label: cardiac pacemaker cell of sinoatrial node
  biological_processes:
  - preferred_term: cardiac conduction
    term:
      id: GO:0061337
      label: cardiac conduction
    modifier: DECREASED
  - preferred_term: regulation of heart rate
    term:
      id: GO:0002027
      label: regulation of heart rate
    modifier: ABNORMAL
  locations:
  - preferred_term: sinoatrial node
    term:
      id: UBERON:0002351
      label: sinoatrial node
  evidence:
  - reference: PMID:21131953
    reference_title: "Loss of Ca(v)1.3 (CACNA1D) function in a human channelopathy with bradycardia and congenital deafness."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "All deaf subjects showed pronounced SAN dysfunction at rest."
    explanation: >-
      Human clinical evidence that sinoatrial node dysfunction is present at
      rest in every affected individual of the founding families.
  - reference: PMID:30498240
    reference_title: "Identification of CACNA1D variants associated with sinoatrial node dysfunction and deafness in additional Pakistani families reveals a clinical significance."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Hence, sinoartrial node dysfunction slows down the pacemaking activity of the heart"
    explanation: >-
      States the causal step from sinoatrial node dysfunction to slowed
      pacemaking in the SANDD families. The source contains the typographical
      error "sinoartrial"; the snippet is quoted verbatim.
  downstream:
  - target: Resting Bradycardia with Increased Heart-Rate Variability
    description: >-
      Depressed and irregular sinoatrial automaticity produces a slow resting
      heart rate with greater beat-to-beat variability.
    evidence:
    - reference: PMID:30498240
      reference_title: "Identification of CACNA1D variants associated with sinoatrial node dysfunction and deafness in additional Pakistani families reveals a clinical significance."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Hence, sinoartrial node dysfunction slows down the pacemaking activity of the heart"
      explanation: >-
        States exactly this causal step, from sinoatrial node dysfunction to a
        slowed heart rate, in the SANDD families. The source spells it
        "sinoartrial"; the snippet is quoted verbatim.
- name: Atrioventricular Conduction Slowing
  role: effector
  biological_scale: TISSUE
  description: >-
    Cav1.3 is expressed in atrioventricular nodal as well as sinoatrial tissue,
    and its loss slows atrioventricular conduction in addition to depressing
    sinoatrial automaticity. Cav1.3-null mice show frank atrioventricular
    block. In humans the abstract-verifiable evidence is limited to the
    observation that P waves did not regularly precede the QRS complex in an
    affected individual, so whether high-grade atrioventricular block is part
    of the human SANDD phenotype is recorded here as an open question rather
    than asserted.
  cell_types:
  - preferred_term: myocyte of atrioventricular node
    term:
      id: CL:1000410
      label: myocyte of atrioventricular node
  biological_processes:
  - preferred_term: cardiac conduction
    term:
      id: GO:0061337
      label: cardiac conduction
    modifier: DECREASED
  locations:
  - preferred_term: atrioventricular node
    term:
      id: UBERON:0002352
      label: atrioventricular node
  evidence:
  - reference: PMID:27374078
    reference_title: "Rescuing cardiac automaticity in L-type Cav1.3 channelopathies and beyond."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "mice show bradycardia and atrioventricular block"
    explanation: >-
      The Cav1.3-null mouse shows atrioventricular block alongside bradycardia,
      establishing the atrioventricular arm in the model organism.
  - reference: PMID:27374078
    reference_title: "Rescuing cardiac automaticity in L-type Cav1.3 channelopathies and beyond."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "L-type Cav 1.3 channels play a major role in the generation and regulation of sino-atrial pacemaker activity and atrioventricular conduction."
    explanation: >-
      Supports Cav1.3 involvement in atrioventricular conduction. Graded PARTIAL
      because it states the physiological role rather than documenting
      atrioventricular block in human SANDD.
  - reference: PMID:30498240
    reference_title: "Identification of CACNA1D variants associated with sinoatrial node dysfunction and deafness in additional Pakistani families reveals a clinical significance."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "P wave did not regularly precede the QRS complex"
    explanation: >-
      The only abstract-verifiable human observation suggesting atrioventricular
      dissociation in SANDD; graded PARTIAL because a single ECG description is
      not a diagnosis of atrioventricular block.
  downstream:
  - target: Exertion- and Stress-Triggered Syncope
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Atrioventricular conduction failure, where present, compounds the
      bradyarrhythmic reduction in cardiac output.
- name: Resting Bradycardia with Increased Heart-Rate Variability
  role: outcome
  biological_scale: ORGANISM
  description: >-
    The clinical cardiac readout of SANDD is a pronounced resting bradycardia
    with increased beat-to-beat variability of heart rate. Reported rates are
    around 48 beats per minute at rest in an affected adolescent, against 60
    beats per minute in a matched control, with a regular but slow rhythm and a
    narrow QRS complex. Chronotropic reserve is limited, so heart rate does not
    rise appropriately with exertion.
  biological_processes:
  - preferred_term: regulation of heart rate
    term:
      id: GO:0002027
      label: regulation of heart rate
    modifier: DECREASED
  evidence:
  - reference: PMID:30498240
    reference_title: "Identification of CACNA1D variants associated with sinoatrial node dysfunction and deafness in additional Pakistani families reveals a clinical significance."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The recorded heart beat rate was 48 beats per minute (bpm) calculated from beat to beat R–R interval"
    explanation: >-
      Quantifies the resting bradycardia and the beat-to-beat measurement in an
      affected individual.
  - reference: PMID:30498240
    reference_title: "Identification of CACNA1D variants associated with sinoatrial node dysfunction and deafness in additional Pakistani families reveals a clinical significance."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We observed a slow heart beat rate along with severe-to-profound deafness in the SANDD-affected individuals"
    explanation: >-
      Confirms the co-occurrence of bradycardia and deafness across the
      replication cohort.
  downstream:
  - target: Exertion- and Stress-Triggered Syncope
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - failure to increase heart rate with physical or emotional stress
    - inadequate cardiac output and cerebral hypoperfusion
    description: >-
      When demand rises with exertion or emotional stress, the bradycardic and
      chronotropically limited sinoatrial node cannot raise cardiac output
      sufficiently, leading to cerebral hypoperfusion and transient loss of
      consciousness.
    evidence:
    - reference: PMID:27374078
      reference_title: "Rescuing cardiac automaticity in L-type Cav1.3 channelopathies and beyond."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "Disease of the sinus node and impairment of atrioventricular conduction induce an excessively low ventricular rate (bradycardia), which cannot meet the needs of the organism."
      explanation: >-
        Supports the demand-mismatch step of this edge, in which the bradycardic
        node cannot meet physiological demand. Graded PARTIAL because it states
        the general physiology of sinus node disease rather than documenting
        exertional syncope in SANDD specifically.
    - reference: PMID:30498240
      reference_title: "Identification of CACNA1D variants associated with sinoatrial node dysfunction and deafness in additional Pakistani families reveals a clinical significance."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Additional features include fatigue, dizziness, and episodic syncope."
      explanation: >-
        Documents the syncopal endpoint co-occurring with the bradycardia in
        SANDD. Graded PARTIAL because the source lists the features rather than
        demonstrating the causal link between them.
- name: Exertion- and Stress-Triggered Syncope
  conforms_to: "cardiac_ion_channel_repolarization#Syncope and Sudden Cardiac Death"
  role: outcome
  biological_scale: ORGANISM
  description: >-
    Episodic syncope, together with fatigue, dizziness, and exertional dyspnea,
    is the symptomatic endpoint of the cardiac arm. Episodes are
    characteristically provoked by enhanced physical activity or emotional
    stress, when the chronotropically limited node cannot meet demand. Note on
    conformance scope: the module node this maps to is named "Syncope and Sudden
    Cardiac Death", but only the syncope arm is documented in SANDD. No sudden
    cardiac death has been reported in the published families, and this entry
    makes no such claim.
  evidence:
  - reference: PMID:30498240
    reference_title: "Identification of CACNA1D variants associated with sinoatrial node dysfunction and deafness in additional Pakistani families reveals a clinical significance."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Additional features include fatigue, dizziness, and episodic syncope."
    explanation: >-
      States the symptomatic endpoints of the cardiac arm of SANDD.
  - reference: PMID:30498240
    reference_title: "Identification of CACNA1D variants associated with sinoatrial node dysfunction and deafness in additional Pakistani families reveals a clinical significance."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "There were no obvious signs of vestibular dysfunction, but he did report the symptoms of fatigue, dizziness, and dyspnea."
    explanation: >-
      Individual-level documentation of the low-output symptom complex
      (fatigue, dizziness, dyspnea) in an affected individual.
- name: Loss of Cav1.3 Calcium Current at the Inner Hair Cell Ribbon Synapse
  role: central_effector
  biological_scale: CELLULAR
  description: >-
    Cochlear inner hair cells convert sound-induced receptor potentials into
    graded glutamate release at specialized ribbon-type active zones. The
    calcium influx that triggers that release is carried almost entirely by
    Cav1.3 channels clustered at the ribbon, where only a small number of open
    channels impose the local nanodomain calcium signal on each release site.
    Non-conducting Cav1.3 therefore silences the presynaptic trigger for
    auditory transmitter release while leaving apical mechanotransduction
    itself intact.
  cell_types:
  - preferred_term: cochlear inner hair cell
    term:
      id: CL:0000589
      label: cochlear inner hair cell
  molecular_functions:
  - preferred_term: voltage-gated calcium channel activity
    term:
      id: GO:0005245
      label: voltage-gated calcium channel activity
    modifier: DECREASED
  biological_processes:
  - preferred_term: neurotransmitter secretion
    term:
      id: GO:0007269
      label: neurotransmitter secretion
    modifier: DECREASED
  locations:
  - preferred_term: cochlea
    term:
      id: UBERON:0001844
      label: cochlea
  evidence:
  - reference: PMID:21131953
    reference_title: "Loss of Ca(v)1.3 (CACNA1D) function in a human channelopathy with bradycardia and congenital deafness."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Ca(v)1.3 voltage-gated L-type calcium channels (LTCCs) translate sound-induced depolarization into neurotransmitter release in auditory hair cells and control diastolic depolarization in the mouse sinoatrial node (SAN)."
    explanation: >-
      Establishes the auditory role of Cav1.3 as the coupler between
      sound-induced depolarization and transmitter release.
  - reference: PMID:16354915
    reference_title: "Few CaV1.3 channels regulate the exocytosis of a synaptic vesicle at the hair cell ribbon synapse."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "We show by immunohistochemistry that the CaV1.3 Ca2+ channels are localized preferentially at the ribbon-type active zones of IHCs."
    explanation: >-
      Localizes Cav1.3 to the inner hair cell ribbon active zone, the site of
      the presynaptic lesion in SANDD.
  - reference: PMID:16354915
    reference_title: "Few CaV1.3 channels regulate the exocytosis of a synaptic vesicle at the hair cell ribbon synapse."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "Our findings suggest a Ca2+ channel-release site coupling in which few nearby CaV1.3 channels impose high nanodomain"
    explanation: >-
      Shows that transmitter release at each active zone depends on a small
      number of Cav1.3 channels imposing a high local nanodomain calcium
      concentration, explaining why their loss is not tolerated.
  downstream:
  - target: Arrested Inner Hair Cell Maturation
    description: >-
      Beyond acutely silencing release, loss of Cav1.3-mediated calcium entry
      removes the spontaneous pre-hearing calcium action potentials that drive
      the inner hair cell's developmental program.
    evidence:
    - reference: PMID:14645476
      reference_title: "CaV1.3 channels are essential for development and presynaptic activity of cochlear inner hair cells."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "CaV1.3-/- IHCs lacked the Ca2+ action potentials and displayed a complex developmental failure."
      explanation: >-
        Directly links loss of the Cav1.3 current to loss of the pre-hearing
        calcium action potentials and to a developmental failure of the inner
        hair cell.
  - target: Failure of Auditory Synaptic Transmission and Hair Cell Degeneration
    description: >-
      Without presynaptic calcium influx, inner hair cells cannot drive the
      auditory nerve; in the mouse null the hair cells subsequently degenerate.
    evidence:
    - reference: PMID:16828974
      reference_title: "Synaptic organization in cochlear inner hair cells deficient for the CaV1.3 (alpha1D) subunit of L-type Ca2+ channels."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "Hence, the block of exocytosis might be solely attributed to the lack of Ca(2+) influx through Ca(V)1.3 channels."
      explanation: >-
        Attributes the block of auditory transmitter release specifically to
        absent Cav1.3 calcium influx rather than to a defect in the release
        machinery, which is the causal step this edge asserts.
- name: Arrested Inner Hair Cell Maturation
  role: amplifier
  biological_scale: CELLULAR
  description: >-
    Cav1.3 does more in the cochlea than trigger release moment to moment: the
    spontaneous calcium action potentials it carries before the onset of
    hearing drive the inner hair cell's own maturation. In the Cav1.3-null
    mouse those spikes are absent and the cell fails to complete its
    developmental program. It does not acquire functional large-conductance
    calcium-activated potassium (BK) channels, retains immature
    small-conductance (SK) channel expression, and abnormally retains efferent
    cholinergic innervation that should normally be withdrawn around the onset
    of hearing. The deafness of SANDD is therefore not only an acute
    transmission block but also a developmental arrest, which is one reason the
    hearing loss is congenital and non-progressive rather than late-onset. This
    arm is currently established only in the mouse.
  cell_types:
  - preferred_term: cochlear inner hair cell
    term:
      id: CL:0000589
      label: cochlear inner hair cell
  biological_processes:
  - preferred_term: inner ear receptor cell development
    term:
      id: GO:0060119
      label: inner ear receptor cell development
    modifier: ABNORMAL
  locations:
  - preferred_term: cochlea
    term:
      id: UBERON:0001844
      label: cochlea
  evidence:
  - reference: PMID:14645476
    reference_title: "CaV1.3 channels are essential for development and presynaptic activity of cochlear inner hair cells."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Most strikingly, we observed a continued presence of efferent cholinergic synaptic transmission and a lack of functional large-conductance Ca2+-activated K+ channels up to 4 weeks after birth."
    explanation: >-
      Documents the two hallmarks of the maturation arrest in the Cav1.3-null
      inner hair cell: retained efferent cholinergic innervation and failure to
      acquire functional BK channels.
  - reference: PMID:14645476
    reference_title: "CaV1.3 channels are essential for development and presynaptic activity of cochlear inner hair cells."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "We conclude that CaV1.3 channels are essential for normal hair cell development and synaptic transmission."
    explanation: >-
      States the dual developmental and synaptic requirement for Cav1.3 in the
      inner hair cell that this node captures.
  - reference: PMID:16828974
    reference_title: "Synaptic organization in cochlear inner hair cells deficient for the CaV1.3 (alpha1D) subunit of L-type Ca2+ channels."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "these data indicate that the Ca(V)1.3 channels are crucially involved in regulation of the expression of BK and SK channels."
    explanation: >-
      Independent confirmation that Cav1.3 controls the BK/SK expression
      switch that marks inner hair cell maturation.
  downstream:
  - target: Failure of Auditory Synaptic Transmission and Hair Cell Degeneration
    description: >-
      An inner hair cell that never matures cannot sustain normal afferent
      signalling, compounding the acute release block and contributing to the
      later loss of synapses and cells.
- name: Failure of Auditory Synaptic Transmission and Hair Cell Degeneration
  role: effector
  biological_scale: TISSUE
  description: >-
    Loss of the inner hair cell L-type calcium current abolishes sound-evoked
    transmitter release to the auditory nerve. In the Cacna1d-null mouse this
    is accompanied by degeneration of both inner and outer hair cells,
    converting a presynaptic transmission failure into structural loss of the
    cochlear sensory epithelium. Direct human cochlear histopathology is not
    available for SANDD, so the degenerative component is currently inferred
    from the mouse model.
  cell_types:
  - preferred_term: cochlear inner hair cell
    term:
      id: CL:0000589
      label: cochlear inner hair cell
  - preferred_term: cochlear outer hair cell
    term:
      id: CL:0000601
      label: cochlear outer hair cell
  biological_processes:
  - preferred_term: sensory perception of sound
    term:
      id: GO:0007605
      label: sensory perception of sound
    modifier: DECREASED
  locations:
  - preferred_term: cochlea
    term:
      id: UBERON:0001844
      label: cochlea
  evidence:
  - reference: PMID:10929716
    reference_title: "Congenital deafness and sinoatrial node dysfunction in mice lacking class D L-type Ca2+ channels."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "alpha1D-/-mice were deaf due to the complete absence of L-type currents in cochlear inner hair cells and degeneration of outer and inner hair cells."
    explanation: >-
      The Cacna1d-null mouse shows loss of inner hair cell L-type current plus
      hair cell degeneration, the model-organism basis for the degenerative
      component of this node.
  - reference: PMID:10929716
    reference_title: "Congenital deafness and sinoatrial node dysfunction in mice lacking class D L-type Ca2+ channels."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "We conclude that alpha1D can form LTCCs with negative activation thresholds essential for normal auditory function and control of cardiac pacemaker activity."
    explanation: >-
      States the dual requirement for Cav1.3 in hearing and cardiac pacemaking
      that the human disorder recapitulates.
  - reference: PMID:16828974
    reference_title: "Synaptic organization in cochlear inner hair cells deficient for the CaV1.3 (alpha1D) subunit of L-type Ca2+ channels."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Despite the near complete block of evoked afferent synaptic transmission, hair cell ribbon synapses were formed and remained preserved for at least 4 weeks after birth."
    explanation: >-
      Establishes the temporal structure of the auditory arm in the model: the
      transmission block comes first and is not caused by failure to build the
      ribbon synapse, which is initially intact.
  - reference: PMID:16828974
    reference_title: "Synaptic organization in cochlear inner hair cells deficient for the CaV1.3 (alpha1D) subunit of L-type Ca2+ channels."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Later on, Ca(V)1.3 deficient IHCs subsequently lost their afferent synapses. This was probably due to a secondary degeneration of the postsynaptic spiral ganglion neurons."
    explanation: >-
      Documents secondary loss of afferent synapses and probable spiral
      ganglion degeneration downstream of the silent synapse, the finding that
      makes the cochlear-implant question in this entry's discussions
      clinically consequential.
  downstream:
  - target: Congenital Severe-to-Profound Sensorineural Deafness
    description: >-
      Absent auditory synaptic transmission, with subsequent hair cell loss,
      produces congenital non-progressive severe-to-profound hearing loss.
- name: Congenital Severe-to-Profound Sensorineural Deafness
  role: outcome
  biological_scale: ORGANISM
  description: >-
    The auditory endpoint is congenital sensorineural hearing loss in the severe
    (71-95 dB) to profound (>95 dB) range affecting all frequencies, present
    from birth and without evidence of accompanying vestibular dysfunction.
  biological_processes:
  - preferred_term: sensory perception of sound
    term:
      id: GO:0007605
      label: sensory perception of sound
    modifier: ABSENT
  locations:
  - preferred_term: cochlea
    term:
      id: UBERON:0001844
      label: cochlea
  evidence:
  - reference: PMID:30498240
    reference_title: "Identification of CACNA1D variants associated with sinoatrial node dysfunction and deafness in additional Pakistani families reveals a clinical significance."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Deafness was congenital and severe (71–95 dB) or profound (>95 dB) in all frequencies for all affected members of the SANDD families"
    explanation: >-
      Audiometric characterization of the hearing loss across all reported
      SANDD families.
mechanistic_hypotheses:
- hypothesis_group_id: cav1_3_two_tissue_divergence
  hypothesis_label: Single-Channel Two-Tissue Divergence Model
  status: CANONICAL
  description: >-
    One Cav1.3 loss-of-function lesion produces two clinically unrelated
    manifestations because the same low-voltage-activated, slowly inactivating
    L-type calcium channel performs two non-redundant jobs in two tissues:
    contributing inward current to diastolic depolarization in sinoatrial node
    pacemaker cells (yielding bradycardia and sinoatrial node dysfunction), and
    supplying the presynaptic calcium influx that triggers graded glutamate
    release at the cochlear inner hair cell ribbon synapse (yielding congenital
    deafness). Neither job can be taken over by the co-expressed Cav1.2
    channel, whose more depolarized activation threshold is unsuitable for
    either. The human phenotype closely recapitulates the Cacna1d-null mouse,
    which supports the model rather than a species-specific mechanism.
  evidence:
  - reference: PMID:21131953
    reference_title: "Loss of Ca(v)1.3 (CACNA1D) function in a human channelopathy with bradycardia and congenital deafness."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Ca(v)1.3 voltage-gated L-type calcium channels (LTCCs) translate sound-induced depolarization into neurotransmitter release in auditory hair cells and control diastolic depolarization in the mouse sinoatrial node (SAN)."
    explanation: >-
      Names both tissue-specific roles of the single channel, the premise of the
      divergence model.
  - reference: PMID:21131953
    reference_title: "Loss of Ca(v)1.3 (CACNA1D) function in a human channelopathy with bradycardia and congenital deafness."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We describe a human channelopathy (termed SANDD syndrome, sinoatrial node dysfunction and deafness) with a cardiac and auditory phenotype that closely resembles that of Cacna1d(-/-) mice."
    explanation: >-
      Confirms that the two-arm human phenotype matches the null mouse,
      supporting a shared single-channel mechanism.
  - reference: PMID:10929716
    reference_title: "Congenital deafness and sinoatrial node dysfunction in mice lacking class D L-type Ca2+ channels."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "We conclude that alpha1D can form LTCCs with negative activation thresholds essential for normal auditory function and control of cardiac pacemaker activity."
    explanation: >-
      The genetic null demonstrates that the negative activation threshold of
      Cav1.3 is required for both functions, explaining the non-redundancy.
discussions:
- discussion_id: gap_sandd_vestibular_sparing
  prompt: >-
    Why is vestibular function spared in SANDD when cochlear inner hair cell
    transmission fails, given that vestibular hair cells also use ribbon
    synapses? Do vestibular hair cells rely on a different calcium channel
    complement (for example a larger Cav1.2 contribution) or on a
    Cav1.3-independent release mode?
  kind: KNOWLEDGE_GAP
  status: OPEN
  attaches_to:
  - pathophysiology#Loss of Cav1.3 Calcium Current at the Inner Hair Cell Ribbon Synapse
  rationale: >-
    Both the MONDO definition and the clinical reports emphasize that affected
    individuals have no evidence of vestibular dysfunction despite congenital
    profound cochlear deafness. Vestibular hair cells use morphologically
    similar ribbon synapses, so their sparing implies a genuine molecular
    difference in the calcium channel complement or in the coupling between
    channels and release sites. Resolving this would refine the mechanism and
    would matter for any future channel-targeted therapy.
  proposed_experiments:
  - experiment_id: exp_sandd_vestibular_channel_complement
    name: Comparative calcium-channel profiling of cochlear versus vestibular hair cells
    description: >-
      Quantify Cav1.3 versus Cav1.2 expression and the calcium current carried
      by each in cochlear inner hair cells and in utricular/saccular vestibular
      hair cells from the same animals, and repeat in a Cav1.3-null background
      to establish which release sites remain functional.
- discussion_id: gap_sandd_human_cochlear_degeneration
  prompt: >-
    Does hair cell degeneration actually occur in the human SANDD cochlea, or
    is the human deafness a pure synaptopathy with a structurally preserved
    organ of Corti? This determines whether cochlear implantation should be
    expected to work as well as in other congenital deafness, and whether a
    presynaptic-targeted therapy could ever be viable.
  kind: HUMAN_MODEL_MISMATCH
  status: OPEN
  attaches_to:
  - pathophysiology#Failure of Auditory Synaptic Transmission and Hair Cell Degeneration
  rationale: >-
    Hair cell degeneration in Cav1.3 deficiency is documented only in the
    Cacna1d-null mouse; no human cochlear histopathology or spiral-ganglion
    imaging has been reported in SANDD. The distinction matters clinically: a
    pure presynaptic synaptopathy with an intact spiral ganglion is the ideal
    substrate for cochlear implantation, whereas secondary degeneration
    extending to the ganglion would predict poorer outcomes. The mouse data
    sharpen rather than settle the question, and they point the wrong way for
    implant candidacy: ribbon synapses are initially built and preserved, but
    the Cav1.3-deficient inner hair cells later lose their afferent synapses,
    probably through secondary degeneration of the postsynaptic spiral ganglion
    neurons (PMID:16828974). If that sequence holds in humans there may be a
    time-limited window in which the auditory nerve is still implantable. The
    question also determines whether the auditory arm is in principle
    reversible by restoring channel function.
  proposed_experiments:
  - experiment_id: exp_sandd_auditory_neuropathy_workup
    name: Electrophysiological and imaging phenotyping of the SANDD auditory pathway
    description: >-
      In genotyped SANDD individuals, combine otoacoustic emissions (to test
      outer hair cell integrity), auditory brainstem response and
      electrocochleography (to localize the block to the synapse versus the
      nerve), and high-resolution cochlear MRI/CT, then correlate with cochlear
      implant outcomes.
- discussion_id: gap_sandd_human_av_block
  prompt: >-
    Does human SANDD include clinically significant atrioventricular conduction
    disease, up to complete heart block, as the Cav1.3-null mouse does, and if
    so at what frequency and at what age?
  kind: HUMAN_MODEL_MISMATCH
  status: OPEN
  attaches_to:
  - pathophysiology#Atrioventricular Conduction Slowing
  rationale: >-
    Cav1.3-null mice show frank atrioventricular block, and review literature
    describes atrioventricular conduction disease within the Cav1.3
    channelopathy spectrum, but the abstract-level human evidence in SANDD
    extends only to a single observation that P waves did not regularly precede
    the QRS. This matters directly for device selection: isolated sinus node
    dysfunction may be treated with atrial pacing, whereas coexisting
    atrioventricular block requires dual-chamber pacing. Systematic Holter and
    electrophysiological characterization of genotyped individuals would
    resolve it.
  proposed_experiments:
  - experiment_id: exp_sandd_conduction_phenotyping
    name: Systematic conduction-system phenotyping of genotyped SANDD individuals
    description: >-
      Perform 12-lead ECG, 24-48 hour Holter, exercise testing for chronotropic
      competence, and where clinically indicated invasive electrophysiological
      study (AH and HV intervals) across the known SANDD pedigrees, reporting
      per-individual atrioventricular conduction status by genotype.
phenotypes:
- category: Auditory
  name: Congenital Severe-to-Profound Sensorineural Deafness
  description: >-
    Congenital, bilateral, non-progressive sensorineural hearing loss in the
    severe (71-95 dB) to profound (>95 dB) range, affecting all frequencies. It
    is the presenting feature in every reported family and is what brought these
    consanguineous pedigrees to genetic attention in the first place.
  phenotype_term:
    preferred_term: Congenital severe-to-profound sensorineural hearing impairment
    term:
      id: HP:0008527
      label: Congenital sensorineural hearing impairment
    severity: SEVERE
  frequency: VERY_FREQUENT
  evidence:
  - reference: PMID:30498240
    reference_title: "Identification of CACNA1D variants associated with sinoatrial node dysfunction and deafness in additional Pakistani families reveals a clinical significance."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Deafness was congenital and severe (71–95 dB) or profound (>95 dB) in all frequencies for all affected members of the SANDD families"
    explanation: >-
      Direct audiometric documentation of congenital severe-to-profound
      sensorineural deafness in all affected family members. The statement that
      it applies to all affected members supports the VERY_FREQUENT band.
  - reference: PMID:21131953
    reference_title: "Loss of Ca(v)1.3 (CACNA1D) function in a human channelopathy with bradycardia and congenital deafness."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "in two consanguineous families with deafness"
    explanation: >-
      Deafness is the ascertaining phenotype of the founding SANDD families.
- category: Cardiovascular
  name: Sinus Bradycardia
  description: >-
    Pronounced resting bradycardia arising from depressed sinoatrial
    automaticity. A representative affected adolescent had a resting rate of 48
    beats per minute with a regular but slow rhythm and a narrow QRS complex,
    against 60 beats per minute in a control.
  phenotype_term:
    preferred_term: Sinus bradycardia
    term:
      id: HP:0001688
      label: Sinus bradycardia
  frequency: VERY_FREQUENT
  evidence:
  - reference: PMID:21131953
    reference_title: "Loss of Ca(v)1.3 (CACNA1D) function in a human channelopathy with bradycardia and congenital deafness."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "All deaf subjects showed pronounced SAN dysfunction at rest."
    explanation: >-
      Every deaf (that is, biallelic) subject in the founding families had
      resting sinoatrial node dysfunction, supporting the VERY_FREQUENT band.
  - reference: PMID:30498240
    reference_title: "Identification of CACNA1D variants associated with sinoatrial node dysfunction and deafness in additional Pakistani families reveals a clinical significance."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The recorded heart beat rate was 48 beats per minute (bpm) calculated from beat to beat R–R interval"
    explanation: >-
      Quantifies the resting bradycardia in an affected individual.
- category: Cardiovascular
  name: Abnormal Electrophysiology of Sinoatrial Node Origin
  description: >-
    Electrocardiographic sinoatrial node dysfunction, detectable at rest in all
    affected individuals: a slow but regular rhythm with a narrow QRS complex
    and P waves that do not regularly precede the QRS.
  phenotype_term:
    preferred_term: Sinoatrial node dysfunction
    term:
      id: HP:0011702
      label: Abnormal electrophysiology of sinoatrial node origin
  frequency: VERY_FREQUENT
  evidence:
  - reference: PMID:21131953
    reference_title: "Loss of Ca(v)1.3 (CACNA1D) function in a human channelopathy with bradycardia and congenital deafness."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "All deaf subjects showed pronounced SAN dysfunction at rest."
    explanation: >-
      Establishes resting sinoatrial node dysfunction as a constant feature in
      the founding families, supporting the VERY_FREQUENT band.
  - reference: PMID:30498240
    reference_title: "Identification of CACNA1D variants associated with sinoatrial node dysfunction and deafness in additional Pakistani families reveals a clinical significance."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "His ECG wave form clearly mark regular but slow rhythm, narrow QRS complex, and P wave did not regularly precede the QRS complex."
    explanation: >-
      Describes the electrocardiographic signature of the sinoatrial node
      dysfunction.
- category: Cardiovascular
  name: Increased Heart Rate Variability
  description: >-
    Increased variability of heart rate at rest, reflecting unstable sinoatrial
    pacemaker output. This is part of the reference clinical description of the
    disorder but is not separately quantified in the primary reports.
  phenotype_term:
    preferred_term: Increased heart rate variability
    term:
      id: HP:0031862
      label: Increased heart rate variability
  notes: >-
    Frequency is intentionally omitted. The increased resting heart-rate
    variability is asserted in the Orphanet-derived MONDO definition of the
    disease but is not accompanied by a per-individual count or a quantitative
    HRV index in the primary literature, so no FrequencyEnum band can be
    justified.
  evidence:
  - reference: PMID:30498240
    reference_title: "Identification of CACNA1D variants associated with sinoatrial node dysfunction and deafness in additional Pakistani families reveals a clinical significance."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The sinoatrial node (SAN) drives heart automaticity and continuously regulates heart rate."
    explanation: >-
      Graded PARTIAL. The primary reports document sinoatrial node dysfunction
      and beat-to-beat R-R measurement but do not report a quantitative
      heart-rate-variability index; this snippet supports only the underlying
      claim that the affected node governs heart rate regulation.
- category: Cardiovascular
  name: Syncope
  description: >-
    Episodic syncope, characteristically triggered by enhanced physical activity
    or emotional stress, when the chronotropically limited sinoatrial node
    cannot raise cardiac output to meet demand.
  phenotype_term:
    preferred_term: Syncope
    term:
      id: HP:0001279
      label: Syncope
    temporality: RECURRENT
  frequency: OCCASIONAL
  evidence:
  - reference: PMID:30498240
    reference_title: "Identification of CACNA1D variants associated with sinoatrial node dysfunction and deafness in additional Pakistani families reveals a clinical significance."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Additional features include fatigue, dizziness, and episodic syncope."
    explanation: >-
      Syncope is listed among the additional (that is, non-constant) features of
      SANDD, which maps to the OCCASIONAL band rather than to a constant
      feature.
- category: Constitutional
  name: Fatigue
  description: >-
    Fatigue attributable to the chronically low cardiac output of untreated
    sinoatrial node dysfunction.
  phenotype_term:
    preferred_term: Fatigue
    term:
      id: HP:0012378
      label: Fatigue
  frequency: OCCASIONAL
  evidence:
  - reference: PMID:30498240
    reference_title: "Identification of CACNA1D variants associated with sinoatrial node dysfunction and deafness in additional Pakistani families reveals a clinical significance."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Additional features include fatigue, dizziness, and episodic syncope."
    explanation: >-
      Fatigue is listed among the additional features of SANDD, mapping to the
      OCCASIONAL band.
- category: Cardiovascular
  name: Presyncopal Dizziness
  description: >-
    Lightheadedness and dizziness reported by affected individuals, occurring
    alongside episodic syncope in the setting of bradycardia. It is attributed
    to low cardiac output and cerebral hypoperfusion rather than to vestibular
    disease, since vestibular function is specifically documented as normal in
    the same individuals.
  phenotype_term:
    preferred_term: Presyncope
    term:
      id: HP:0031972
      label: Presyncope
  frequency: OCCASIONAL
  notes: >-
    Term choice is deliberate. HPO has no free-standing "dizziness" term at
    this level of granularity; the obvious candidate, HP:0002321 Vertigo, is
    `is_a` HP:0001751 Abnormal vestibular function and would therefore assert
    exactly the vestibular involvement that the source explicitly excludes and
    that this entry's `gap_sandd_vestibular_sparing` discussion treats as an
    open question. HP:0031972 Presyncope is `is_a` HP:0011025 Abnormal
    cardiovascular system physiology and is defined as "a state of
    lightheadedness, muscular weakness, blurred vision, and feeling faint",
    "most often cardiovascular in cause", which matches the mechanism curated
    here. The sources say "dizziness" rather than "presyncope", so the mapping
    evidence is graded PARTIAL.
  evidence:
  - reference: PMID:30498240
    reference_title: "Identification of CACNA1D variants associated with sinoatrial node dysfunction and deafness in additional Pakistani families reveals a clinical significance."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "There were no obvious signs of vestibular dysfunction, but he did report the symptoms of fatigue, dizziness, and dyspnea."
    explanation: >-
      Documents dizziness in an affected individual while explicitly excluding
      vestibular dysfunction as its cause, which is what licenses binding this
      symptom to the cardiovascular Presyncope term rather than to Vertigo.
      Graded PARTIAL because the source records "dizziness" and does not itself
      use the word presyncope.
  - reference: PMID:30498240
    reference_title: "Identification of CACNA1D variants associated with sinoatrial node dysfunction and deafness in additional Pakistani families reveals a clinical significance."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Additional features include fatigue, dizziness, and episodic syncope."
    explanation: >-
      Places dizziness alongside frank syncope in the same symptom cluster,
      supporting a presyncopal rather than vestibular interpretation, and
      listing it among the additional (non-constant) features that map to the
      OCCASIONAL band.
- category: Respiratory
  name: Exertional Dyspnea
  description: >-
    Breathlessness reported by an affected individual, consistent with the
    limited chronotropic reserve of the dysfunctional sinoatrial node.
  phenotype_term:
    preferred_term: Dyspnea
    term:
      id: HP:0002094
      label: Dyspnea
  notes: >-
    Frequency omitted: dyspnea is documented in a single affected individual in
    the replication cohort, which is below the threshold at which a
    FrequencyEnum band can be justified.
  evidence:
  - reference: PMID:30498240
    reference_title: "Identification of CACNA1D variants associated with sinoatrial node dysfunction and deafness in additional Pakistani families reveals a clinical significance."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "There were no obvious signs of vestibular dysfunction, but he did report the symptoms of fatigue, dizziness, and dyspnea."
    explanation: >-
      Single-individual documentation of dyspnea in the replication cohort.
diagnosis:
- name: Electrocardiography and ambulatory (Holter) rhythm monitoring
  description: >-
    A resting 12-lead ECG establishes the sinoatrial abnormality: a slow but
    regular rhythm with a narrow QRS complex, P waves that do not regularly
    precede the QRS, and a normal QT interval (which is what separates SANDD at
    the bedside from Jervell and Lange-Nielsen syndrome). Ambulatory Holter
    recording quantifies the mean and minimum rate and captures pauses; Holter
    tracings from genotyped SANDD homozygotes are published. Exercise testing
    is used to demonstrate chronotropic incompetence when exertional symptoms
    are present.
  presence: >-
    Resting bradycardia with sinoatrial node dysfunction was present in every
    affected individual across the reported families, so a normal resting ECG
    argues strongly against the diagnosis in a congenitally deaf proband.
  diagnosis_term:
    preferred_term: electrocardiography
    term:
      id: NCIT:C38053
      label: Electrocardiography
  evidence:
  - reference: PMID:30498240
    reference_title: "Identification of CACNA1D variants associated with sinoatrial node dysfunction and deafness in additional Pakistani families reveals a clinical significance."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "His ECG wave form clearly mark regular but slow rhythm, narrow QRS complex, and P wave did not regularly precede the QRS complex."
    explanation: >-
      Describes the diagnostic electrocardiographic signature recorded in an
      affected individual.
  - reference: PMID:21131953
    reference_title: "Loss of Ca(v)1.3 (CACNA1D) function in a human channelopathy with bradycardia and congenital deafness."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "All deaf subjects showed pronounced SAN dysfunction at rest."
    explanation: >-
      Supports resting electrocardiographic assessment as sufficient to detect
      the cardiac abnormality, which was present at rest in all affected
      individuals.
- name: Ambulatory Holter monitoring
  description: >-
    Continuous ambulatory ECG quantifies mean, maximum, and minimum heart rate
    over the day-night cycle and documents sinus pauses. Holter recordings from
    homozygous SANDD subjects have been published and reproduced in review
    figures.
  diagnosis_term:
    preferred_term: Holter monitoring
    term:
      id: NCIT:C38064
      label: Holter Monitoring
  evidence:
  - reference: PMID:27374078
    reference_title: "Rescuing cardiac automaticity in L-type Cav1.3 channelopathies and beyond."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "sample Holter ECG recordings from individuals with normal heart rate (a), or from SANDD affected subjects, who were homozygous for the mutation"
    explanation: >-
      Confirms that Holter monitoring has been applied to genotyped SANDD
      homozygotes and used to characterize their rhythm against controls.
- name: Audiometric assessment
  description: >-
    Pure-tone audiometry, supplemented in infancy by auditory brainstem
    response and otoacoustic emission testing, establishes the degree and
    configuration of the hearing loss. In SANDD it is congenital, bilateral,
    and severe (71-95 dB) to profound (>95 dB) across all frequencies, and
    formal vestibular assessment has not shown accompanying vestibular
    dysfunction.
  presence: >-
    Congenital severe-to-profound sensorineural hearing loss across all
    frequencies, with clinically normal vestibular function.
  diagnosis_term:
    preferred_term: audiometric testing
    term:
      id: NCIT:C38036
      label: Audiometric Test
  evidence:
  - reference: PMID:30498240
    reference_title: "Identification of CACNA1D variants associated with sinoatrial node dysfunction and deafness in additional Pakistani families reveals a clinical significance."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Deafness was congenital and severe (71–95 dB) or profound (>95 dB) in all frequencies for all affected members of the SANDD families"
    explanation: >-
      Reports the audiometric thresholds that define the auditory arm of the
      diagnosis.
  - reference: PMID:30498240
    reference_title: "Identification of CACNA1D variants associated with sinoatrial node dysfunction and deafness in additional Pakistani families reveals a clinical significance."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "There were no obvious signs of vestibular dysfunction"
    explanation: >-
      Documents the negative vestibular finding that accompanies the audiometric
      result and helps separate SANDD from syndromic deafness with vestibular
      involvement.
- name: CACNA1D molecular genetic testing
  description: >-
    Molecular confirmation requires two pathogenic CACNA1D loss-of-function
    alleles in trans in an individual with a compatible phenotype. In families
    of Khyber Pakhtunkhwa origin, targeted testing for the founder
    p.(Gly403_Val404insGly) allele is the efficient first step; otherwise
    CACNA1D sequencing, a combined hearing-loss/arrhythmia panel, or exome
    sequencing is appropriate. Parental testing confirms phase and segregation.
    Interpretation must be direction-aware: heterozygous CACNA1D variants,
    particularly gain-of-function ones, cause mechanistically distinct dominant
    disorders and do not establish SANDD.
  diagnosis_term:
    preferred_term: genetic testing
    term:
      id: NCIT:C15709
      label: Genetic Testing
  evidence:
  - reference: PMID:30498240
    reference_title: "Identification of CACNA1D variants associated with sinoatrial node dysfunction and deafness in additional Pakistani families reveals a clinical significance."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We studied five Pakistani families with SANDD and characterized a new missense variant p.(A376V) in CACNA1D in one family, and further characterized the founder variant p.(G403_V404insG) in four additional pedigrees."
    explanation: >-
      Documents the two CACNA1D alleles that molecular testing is looking for,
      including the recurrent founder variant.
  - reference: PMID:36430690
    reference_title: "Whole Exome Sequencing Identifies a Heterozygous Variant in the Cav1.3 Gene CACNA1D Associated with Familial Sinus Node Dysfunction and Focal Idiopathic Epilepsy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "So far, homozygous loss of function mutations in CACNA1D encoding the Cav1.3 α1-subunit are described in congenital sinus node dysfunction and deafness."
    explanation: >-
      States the zygosity and functional-direction requirement that makes a
      molecular diagnosis of SANDD, as opposed to one of the heterozygous
      CACNA1D disorders.
- name: Cardiac screening of individuals with congenital deafness
  description: >-
    Because deafness is the ascertaining feature and the bradycardia may be
    clinically silent, electrocardiographic screening of individuals with
    congenital deafness in the founder region is recommended, so that affected
    individuals enter cardiac follow-up before symptomatic sinus node failure
    develops. The same logic underlies the long-standing practice of screening
    congenitally deaf children for the QT prolongation of Jervell and
    Lange-Nielsen syndrome.
  diagnosis_term:
    preferred_term: disease screening
    term:
      id: NCIT:C15419
      label: Disease Screening
  notes: >-
    Relocated from `treatments:` to `diagnosis:` because this is a case-finding
    procedure that detects the sinoatrial phenotype rather than a therapeutic
    action that treats it.
  evidence:
  - reference: PMID:30498240
    reference_title: "Identification of CACNA1D variants associated with sinoatrial node dysfunction and deafness in additional Pakistani families reveals a clinical significance."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Therefore, screening patients with congenital deafness for SAN dysfunction in this province could ensure adequate follow-up and prevent cardiac failure associated with SAN."
    explanation: >-
      The replication study explicitly recommends screening congenitally deaf
      individuals in the founder region for sinoatrial node dysfunction.
- name: Echocardiography to exclude structural heart disease
  description: >-
    Echocardiography is used to confirm that the heart is structurally normal,
    which is a defining condition of the inherited-channelopathy framing that
    places SANDD in the cardiac ion-channel module, and to exclude structural
    or cardiomyopathic causes of bradyarrhythmia. It also separates SANDD from
    HCN4-related bradycardia with left ventricular noncompaction and from
    LMNA-related conduction disease with cardiomyopathy.
  diagnosis_term:
    preferred_term: echocardiography
    term:
      id: NCIT:C16525
      label: Echocardiography Test
  notes: >-
    No SANDD-specific imaging series has been published, so no evidence item is
    attached. This entry lists echocardiography as the standard exclusion step
    for structural causes of bradyarrhythmia rather than citing a stretched
    source; the project's evidence policy prefers an unevidenced description to
    a fabricated or over-reaching citation.
treatments:
- name: Permanent Cardiac Pacemaker Implantation
  description: >-
    Electronic pacing is the only established therapy for symptomatic sinus
    node dysfunction and is the mechanism-directed intervention for the cardiac
    arm of SANDD: it substitutes an artificial pacemaker for the failed
    Cav1.3-dependent sinoatrial automaticity. No SANDD-specific pacing series
    has been published, so the indication is extrapolated from general sick
    sinus syndrome management and the evidence below is graded accordingly.
    Device choice depends on whether atrioventricular conduction is also
    involved, which is an open question for this disorder.
  therapeutic_modality: DEVICE
  action_category: THERAPEUTIC
  treatment_term:
    preferred_term: pacemaker placement
    term:
      id: NCIT:C80434
      label: Pacemaker Placement
  target_mechanisms:
  - target: Sinoatrial Node Pacemaker Dysfunction
    treatment_effect: BYPASSES
    description: >-
      Pacing does not restore the Cav1.3 current; it bypasses the failed
      sinoatrial pacemaker by imposing an external rhythm.
    evidence:
    - reference: PMID:27374078
      reference_title: "Rescuing cardiac automaticity in L-type Cav1.3 channelopathies and beyond."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "Implantation of an electronic pacemaker constitutes the only available therapy for SSS."
      explanation: >-
        A review of Cav1.3 channelopathies states that electronic pacing is the
        only available therapy for sick sinus syndrome. Graded PARTIAL because
        the statement is about sick sinus syndrome in general rather than a
        SANDD-specific outcome series.
  target_phenotypes:
  - preferred_term: Sinus bradycardia
    term:
      id: HP:0001688
      label: Sinus bradycardia
  - preferred_term: Syncope
    term:
      id: HP:0001279
      label: Syncope
  evidence:
  - reference: PMID:27374078
    reference_title: "Rescuing cardiac automaticity in L-type Cav1.3 channelopathies and beyond."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Implantation of an electronic pacemaker constitutes the only available therapy for SSS."
    explanation: >-
      Supports pacing as the standard and only established therapy for the sick
      sinus phenotype; PARTIAL because it is not a SANDD-specific report.
- name: Cochlear Implantation
  description: >-
    Surgical cochlear implantation is the standard habilitation for congenital
    severe-to-profound sensorineural hearing loss and is the pragmatic option
    for the auditory arm of SANDD. No SANDD-specific implantation outcome data
    have been published; whether the underlying lesion is a pure presynaptic
    synaptopathy with a preserved spiral ganglion, which would predict good
    implant outcomes, is recorded as an open question in this entry's
    discussions.
  therapeutic_modality: SURGERY
  action_category: THERAPEUTIC
  treatment_term:
    preferred_term: cochlear implantation
    term:
      id: NCIT:C15329
      label: Surgical Procedure
  target_phenotypes:
  - preferred_term: Congenital sensorineural hearing impairment
    term:
      id: HP:0008527
      label: Congenital sensorineural hearing impairment
  notes: >-
    Listed as standard-of-care habilitation by analogy with other congenital
    severe-to-profound sensorineural hearing loss. No evidence item is attached
    because no citable source reports cochlear implantation specifically in
    genotyped SANDD individuals, and the project's evidence policy prefers an
    unevidenced description over a stretched citation.
- name: Genetic Counseling
  description: >-
    Autosomal recessive counseling for consanguineous families, including the
    25% per-pregnancy recurrence risk for carrier couples and the availability
    of targeted testing for the founder p.Gly403_Val404insGly allele in families
    of Khyber Pakhtunkhwa origin. Heterozygous carriers are unaffected.
  therapeutic_modality: OTHER
  action_category: COUNSELING_INFORMATIONAL
  treatment_term:
    preferred_term: genetic counseling
    term:
      id: NCIT:C15240
      label: Genetic Counseling
  evidence:
  - reference: PMID:30498240
    reference_title: "Identification of CACNA1D variants associated with sinoatrial node dysfunction and deafness in additional Pakistani families reveals a clinical significance."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We show that affected individuals in the four families which segregate p.(G403_V404insG) share a 1.03 MB haplotype on 3p21.1 suggesting they share a common distant ancestor."
    explanation: >-
      Supports the founder-allele basis for targeted carrier testing in this
      population. Graded PARTIAL because the paper documents the founder
      haplotype rather than counseling practice itself.
- name: G-Protein-Gated Potassium (IKACh) Channel Inhibition
  description: >-
    An experimental, mechanism-directed strategy that does not replace the lost
    Cav1.3 current but removes an opposing hyperpolarizing current. Genetic or
    pharmacological ablation of the acetylcholine-activated inward-rectifier
    potassium current IKACh, for example with the GIRK pore blocker
    tertiapin-Q, rescues pacemaker activity in Cav1.3-null mice. This is
    preclinical only: no human SANDD trial exists, and the concept is included
    to record the therapeutic hypothesis attached to the mechanism, not to
    recommend treatment. Note the contrast with the dominant CACNA1D
    gain-of-function disorders, where Cav1.3 blockade is the rational strategy;
    blocking an already non-conducting channel would be pointless in SANDD.
  therapeutic_modality: SMALL_MOLECULE
  action_category: THERAPEUTIC
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
  target_mechanisms:
  - target: Sinoatrial Node Pacemaker Dysfunction
    treatment_effect: INHIBITS
    description: >-
      Blocking the opposing IKACh current shifts the net balance of sinoatrial
      currents toward depolarization, partially compensating for the absent
      Cav1.3 inward current.
    evidence:
    - reference: PMID:27374078
      reference_title: "Rescuing cardiac automaticity in L-type Cav1.3 channelopathies and beyond."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "Work in our laboratory shows that targeting G protein-gated K+ (IKACh ) channels effectively rescues SSS of Cav 1.3-/- mice."
      explanation: >-
        Demonstrates compensatory-channel targeting as a mechanism-directed
        rescue of the sick sinus phenotype in the Cav1.3-null model.
  evidence:
  - reference: PMID:27374078
    reference_title: "Rescuing cardiac automaticity in L-type Cav1.3 channelopathies and beyond."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "This new concept of 'compensatory' ion channel targeting shines new light on the principles underlying the pacemaker mechanism and may open the way to new therapies for SSS."
    explanation: >-
      Frames compensatory ion-channel targeting as a candidate future therapy
      for sinus node dysfunction, currently supported only in the mouse.
📚

References & Deep Research

Deep Research

1
Falcon ▸
Sinoatrial Node Dysfunction and Deafness (SANDD): Comprehensive Disease-Characteristics Report
Edison Scientific Literature 19 citations 2026-08-01T18:36:07.983678

Sinoatrial Node Dysfunction and Deafness (SANDD): Comprehensive Disease-Characteristics Report

Executive summary and evidence scope

Sinoatrial node dysfunction and deafness (SANDD) is an ultra-rare, autosomal-recessive calcium-channelopathy caused by biallelic loss-of-function variants in CACNA1D, which encodes the pore-forming α1D subunit of the CaV1.3 L-type voltage-gated calcium channel. The defining manifestations are congenital sensorineural deafness and early-onset sinoatrial-node dysfunction, often accompanied by atrioventricular conduction disease. The strongest human evidence remains a small number of consanguineous families; therefore, prevalence, penetrance, long-term survival, quality-of-life, and treatment-response estimates are not available at population level. Open Targets maps only CACNA1D to this disease, supported principally by the original human study, PMID 21131953. (OpenTargets Search: Sinoatrial node dysfunction and deafness-CACNA1D, torrente2020channelopathiesofvoltagegated pages 5-7)

This report distinguishes classic SANDD—biallelic CACNA1D loss of function—from dominant/de novo CACNA1D disorders caused by gain of function or transcript-dependent mixed effects. Those disorders may produce epilepsy, autism, developmental disability, primary aldosteronism, or hyperinsulinism and must not be merged with SANDD. (rinne2022wholeexomesequencing pages 2-4, rinne2022wholeexomesequencing pages 1-2, rinne2022wholeexomesequencing pages 9-11)

The following table provides a knowledge-base-oriented synopsis.

Domain Key finding Suggested ontology/ID(s) Evidence type Citation
Disease identifier Sinoatrial node dysfunction and deafness (SANDD); ultra-rare Mendelian channelopathy caused by CACNA1D loss of function; MONDO disease mapping available MONDO:0013960; OMIM:614896 Established human disease mapping (OpenTargets Search: Sinoatrial node dysfunction and deafness-CACNA1D, torrente2020channelopathiesofvoltagegated pages 5-7)
Synonyms SANDD; sino-atrial node dysfunction and deafness; sinus node dysfunction and deafness MONDO:0013960 Aggregated disease resource + literature (OpenTargets Search: Sinoatrial node dysfunction and deafness-CACNA1D, mesirca2016rescuingcardiacautomaticity pages 1-2)
Causal gene CACNA1D encodes CaV1.3/L-type voltage-gated calcium channel alpha1D, the only consistently implicated disease gene HGNC:1392; Ensembl:ENSG00000157388 Established human genetics (OpenTargets Search: Sinoatrial node dysfunction and deafness-CACNA1D, torrente2020channelopathiesofvoltagegated pages 5-7)
Core molecular mechanism Biallelic CACNA1D loss of function abolishes or markedly reduces CaV1.3-mediated inward Ca2+ current in sinoatrial/atrioventricular nodal cells and cochlear inner hair cells, impairing pacemaking and auditory transduction/development GO:0005245 voltage-gated calcium channel activity; GO:0060048 cardiac muscle contraction?; GO:0086001 cardiac muscle cell action potential; GO:0006816 calcium ion transport Human functional inference supported by model/heterologous data (torrente2020channelopathiesofvoltagegated pages 7-9, torrente2020channelopathiesofvoltagegated pages 5-7, rinne2022wholeexomesequencing pages 1-2, torrente2020channelopathiesofvoltagegated pages 22-24)
Pathogenic variants Recurrent SANDD variant reported as p.Gly403dup / p.403_404insGly / p.403-404InsGly (3-bp insertion in alternatively spliced exon 8B); another reported SANDD-associated missense variant p.Ala376Val HGVS protein: p.Gly403dup; p.Ala376Val Established human variant-level evidence (torrente2020channelopathiesofvoltagegated pages 5-7, torrente2020channelopathiesofvoltagegated pages 7-9)
Variant effect p.Gly403dup mutant channels traffic to plasma membrane but are electrically silent/non-conducting; likely uncouples gating from pore opening or sterically impairs ion permeation GO:1901385 regulation of membrane depolarization? Human mutation with in vitro functional evidence (torrente2020channelopathiesofvoltagegated pages 7-9, torrente2020channelopathiesofvoltagegated pages 5-7)
Inheritance Autosomal recessive / biallelic disease; heterozygous relatives reported as clinically unaffected in classic SANDD families HP:0000007 Autosomal recessive inheritance Established human pedigree evidence (torrente2020channelopathiesofvoltagegated pages 7-9, torrente2020channelopathiesofvoltagegated pages 5-7)
Population / founder context Reported in seven consanguineous Pakistani families from Khyber Pakhtunkhwa province; indicates strong founder/consanguinity contribution in known cases HP:0003765 Increased consanguinity Established human family-series evidence (torrente2020channelopathiesofvoltagegated pages 5-7)
Epidemiology No robust prevalence or incidence estimates identified; evidence limited to a handful of families/case reports MONDO:0013960 Evidence gap (torrente2020channelopathiesofvoltagegated pages 5-7)
Cardiac phenotype Severe sinus bradycardia, sinus node dysfunction, sinus pauses, SAN exit block, atrioventricular conduction disease ranging from 2nd-degree AV block to complete heart block; exercise-related dizziness/fatigue/syncope reported HP:0001649 Bradycardia; HP:0001677 Cardiac syncope; HP:0011706 Second degree atrioventricular block; HP:0004762 Complete atrioventricular block Established human clinical evidence (torrente2020channelopathiesofvoltagegated pages 7-9)
Quantitative cardiac data Reported daytime heart rates ~38-52 bpm and nocturnal heart rates below 35 bpm in homozygous affected individuals HP:0001649 Bradycardia Established human quantitative evidence (torrente2020channelopathiesofvoltagegated pages 7-9)
Auditory phenotype Congenital/profound sensorineural deafness or hearing loss is a defining feature of classic SANDD HP:0000407 Sensorineural hearing impairment; HP:0008619 Congenital hearing impairment Established human clinical evidence (rinne2022wholeexomesequencing pages 2-4, rinne2022wholeexomesequencing pages 1-2)
Typical onset/course Congenital or early-life onset for deafness; cardiac conduction disease present in childhood and appears chronic/lifelong rather than remitting HP:0003577 Congenital onset Human cases + inference from syndrome description (rinne2022wholeexomesequencing pages 2-4, torrente2020channelopathiesofvoltagegated pages 7-9, rinne2022wholeexomesequencing pages 1-2)
Key affected organs Heart conduction system and inner ear/cochlea are primary organs directly affected UBERON:0000948 heart; UBERON:0001844 inner ear; UBERON:0001690 cochlea Established from human and model evidence (torrente2020channelopathiesofvoltagegated pages 7-9, rinne2022wholeexomesequencing pages 1-2, torrente2020channelopathiesofvoltagegated pages 22-24)
Key tissues/cells Sinoatrial node pacemaker cells, atrioventricular nodal cells, cochlear inner hair cells UBERON:0000079 sinoatrial node; UBERON:0000086 atrioventricular node; CL:0000586 hearing receptor cell; inner hair cell term not asserted with confidence Human/mechanistic/model evidence (mesirca2016rescuingcardiacautomaticity pages 3-5, torrente2020channelopathiesofvoltagegated pages 5-7, rinne2022wholeexomesequencing pages 1-2)
SAN electrophysiology CaV1.3 activates at more negative voltages than CaV1.2 (about -45 mV vs -25 mV), contributing directly to diastolic depolarization; under beta-adrenergic stimulation threshold may extend to about -55 to -60 mV GO:0086012 membrane depolarization during cardiac muscle cell action potential Mechanistic evidence from experimental studies summarized in reviews (torrente2020channelopathiesofvoltagegated pages 5-7, torrente2020channelopathiesofvoltagegated pages 9-11)
Upstream/downstream causal chain CACNA1D LoF -> reduced nodal diastolic inward Ca2+ current and impaired RyR2/NCX-coupled pacemaker activity -> slowed SAN automaticity and AV conduction -> bradycardia, pauses, syncope; CACNA1D LoF in inner hair cells -> absent L-type Ca2+ signaling and arrested maturation/degeneration -> congenital deafness GO:0006936 muscle contraction process not specific; GO:0001508 action potential; GO:0006816 calcium ion transport Mechanistic synthesis from human, in vitro, and model evidence (torrente2020channelopathiesofvoltagegated pages 7-9, torrente2020channelopathiesofvoltagegated pages 5-7, torrente2020channelopathiesofvoltagegated pages 9-11, torrente2020channelopathiesofvoltagegated pages 22-24)
Diagnostics: clinical ECG/Holter monitoring for sinus bradycardia, pauses, SAN exit block, and AV block; audiologic testing for congenital sensorineural deafness; family history and consanguinity assessment are relevant LOINC/ECG not asserted; HP:0001649; HP:0000407 Established clinical practice inference from reported phenotypes (torrente2020channelopathiesofvoltagegated pages 7-9, mesirca2016rescuingcardiacautomaticity pages 1-2)
Diagnostics: genetic Priority testing methods: CACNA1D single-gene analysis if syndrome suspected; broader arrhythmia/deafness panels, WES/WGS if phenotype nonspecific; testing should distinguish recessive LoF SANDD from dominant CACNA1D gain-of-function neurodevelopmental syndromes HGNC:1392; MONDO:0013960 Expert/clinical inference anchored in known gene-disease relationship (OpenTargets Search: Sinoatrial node dysfunction and deafness-CACNA1D, rinne2022wholeexomesequencing pages 2-4, rinne2022wholeexomesequencing pages 1-2)
Management No disease-specific drug therapy established; symptomatic management centers on pacemaker implantation for clinically significant sinus node dysfunction/conduction disease; hearing rehabilitation may include hearing aids/cochlear implant based on audiology, though syndrome-specific outcome data are lacking NCIT:C17754 Cardiac Pacemaker Implantation Standard-of-care inference + SND review evidence (mesirca2016rescuingcardiacautomaticity pages 1-2, torrente2020channelopathiesofvoltagegated pages 7-9)
Prognosis Morbidity likely driven by chronic bradyarrhythmia/syncope and lifelong deafness; syndrome-specific survival, QoL, and natural-history statistics not identified MONDO:0013960 Evidence gap with cautious inference (torrente2020channelopathiesofvoltagegated pages 7-9, mesirca2016rescuingcardiacautomaticity pages 1-2)
Distinction from other CACNA1D disorders Classic SANDD is biallelic loss-of-function with deafness and nodal disease; distinct from heterozygous CACNA1D disorders such as dominant mixed LoF/GoF sinus node dysfunction with epilepsy (p.Arg930His) and de novo gain-of-function neurodevelopmental/endocrine syndromes, which may lack deafness MONDO:0013960 Established genotype-phenotype distinction (rinne2022wholeexomesequencing pages 2-4, rinne2022wholeexomesequencing pages 1-2, rinne2022wholeexomesequencing pages 9-11, ortner2024iscav1.3a pages 6-6)
Animal model: global knockout Cacna1d/CaV1.3-null mice recapitulate bradycardia, sinoatrial dysfunction, AV block, and deafness; useful for mechanism and therapeutic proof-of-concept NCBITaxon:10090 Established model-organism evidence (mesirca2016rescuingcardiacautomaticity pages 3-5, torrente2020channelopathiesofvoltagegated pages 7-9, mesirca2016rescuingcardiacautomaticity pages 1-2, torrente2020channelopathiesofvoltagegated pages 22-24)
Quantitative model data Global CaV1.3 knockout mice show ~60-70% reduction in SAN ICa,L density GO:0005245 Model quantitative evidence (mesirca2016rescuingcardiacautomaticity pages 3-5)
Auditory model findings Systemic and cochlea-specific Cacna1d deletion causes profound hearing loss; inner hair cells remain immature with absent BK upregulation and persistent SK2 expression; degeneration can occur in systemic null mice GO:0042491 inner ear auditory receptor cell differentiation; GO:0005249 voltage-gated potassium channel activity Established model evidence (rinne2022wholeexomesequencing pages 1-2)
Experimental therapy signals In mice, IKACh inhibition rescued bradycardia/automaticity in CaV1.3 channelopathy models; this is preclinical and not established for human SANDD NCIT not asserted; GO:0005227 calcium-activated cation channel activity not specific Model/preclinical evidence (mesirca2016rescuingcardiacautomaticity pages 1-2, torrente2020channelopathiesofvoltagegated pages 9-11)
Recent developments (2023-2024) Recent reviews emphasize CaV1.3 as a nodal-specific therapeutic target and summarize new CACNA1D variant models; 2024 isradipine work pertains to CACNA1D gain-of-function neurodevelopmental/endocrine disease, not SANDD loss of function MONDO:0013960 Recent expert analysis; indirect relevance (ortner2024iscav1.3a pages 6-6)
Environmental / infectious factors No convincing environmental, lifestyle, toxin, or infectious causes identified for classic SANDD; gene-environment and epigenetic modifiers remain unproven Not applicable Evidence gap (torrente2020channelopathiesofvoltagegated pages 5-7, torrente2020channelopathiesofvoltagegated pages 7-9)
Data provenance Information derives from aggregated disease/gene resources plus a very small number of human families and supporting in vitro/mouse studies, not EHR-scale cohorts MONDO:0013960 Evidence appraisal (OpenTargets Search: Sinoatrial node dysfunction and deafness-CACNA1D, torrente2020channelopathiesofvoltagegated pages 5-7, mesirca2016rescuingcardiacautomaticity pages 1-2)

Table: This table condenses the most actionable disease-knowledge elements for Sinoatrial Node Dysfunction and Deafness, including identifiers, gene-mechanism links, phenotypes, models, and explicit evidence gaps. It is designed for direct knowledge-base extraction while separating established human evidence from model-supported inference.

1. Disease information

Definition and identifiers

SANDD is a congenital syndromic disorder linking failure of cardiac pacemaking with deafness. It is classified as a Mendelian channelopathy.

  • Preferred name: Sinoatrial node dysfunction and deafness
  • Synonyms: SANDD; SANDD syndrome; sinus node dysfunction and deafness; sino-atrial node dysfunction and deafness
  • MONDO: MONDO:0013960
  • OMIM phenotype: 614896
  • Causal gene: CACNA1D, Ensembl ENSG00000157388, encoding calcium voltage-gated channel subunit α1D/CaV1.3 (OpenTargets Search: Sinoatrial node dysfunction and deafness-CACNA1D, torrente2020channelopathiesofvoltagegated pages 5-7)
  • MeSH: No disease-specific MeSH descriptor was identified; broader descriptors include Sick Sinus Syndrome, Bradycardia, and Hearing Loss, Sensorineural.
  • ICD-10/ICD-11: No SANDD-specific code was identified. Component manifestations would ordinarily be coded separately—for example, sick sinus syndrome/conduction disease and congenital sensorineural hearing loss.
  • Orphanet: No confidently verified disease-specific Orphanet identifier was recovered in the searched evidence; it should not be inferred from OMIM or MONDO.

Data provenance

The evidence is aggregated disease-level information derived from published pedigrees, functional expression studies, and animal models, not an EHR-scale patient dataset. Seven consanguineous Pakistani families have been described in the literature synthesis, but detailed denominators and standardized phenotype frequencies are unavailable. (torrente2020channelopathiesofvoltagegated pages 5-7)

2. Etiology, risk, and protective factors

Causal factor

The primary cause is germline biallelic CACNA1D loss of function. The best-characterized recurrent lesion is a three-base-pair insertion in alternatively spliced exon 8B, variously reported as p.Gly403dup, p.403_404insGly, or p.403-404InsGly. The mutant protein reaches the plasma membrane but generates no functional Ca²⁺ current, indicating a channel-conduction/gating defect rather than simple trafficking failure. A second reported SANDD-associated missense variant is p.Ala376Val. (rinne2022wholeexomesequencing pages 9-11, torrente2020channelopathiesofvoltagegated pages 7-9, torrente2020channelopathiesofvoltagegated pages 5-7)

Risk factors

  • Genetic: Homozygosity or compound biallelic pathogenic CACNA1D loss-of-function variants is the principal risk. Heterozygous relatives in the classic pedigrees were clinically unaffected, supporting recessive inheritance. (torrente2020channelopathiesofvoltagegated pages 7-9)
  • Family structure: Consanguinity and ancestry from a founder population are important ascertainment/risk factors in the known families. The recurrent insertion has been reported across seven consanguineous families from Khyber Pakhtunkhwa, Pakistan. (torrente2020channelopathiesofvoltagegated pages 5-7)
  • Environmental, infectious, occupational, lifestyle, age, or sex risks: None are established for occurrence of this congenital Mendelian disorder.
  • Modifiers: No validated modifier genes are known. Variable cardiac severity could plausibly reflect other pacemaker-current genes, autonomic tone, medications, or epigenetic background, but this remains unproven for SANDD.

Protective factors and gene–environment interactions

No protective allele, diet, exposure, medication, or lifestyle intervention has been shown to prevent SANDD. Avoidance of drugs that further depress sinoatrial or atrioventricular conduction is clinically prudent but is tertiary risk management, not primary prevention. No SANDD-specific gene–environment interaction has been demonstrated.

3. Phenotypes

Core phenotype profile

  1. Congenital sensorineural hearing impairment/deafness—a defining, generally severe-to-profound phenotype. Suggested terms: HP:0000407 Sensorineural hearing impairment, HP:0008619 Congenital hearing impairment. Mouse and human evidence localizes the defect to CaV1.3-dependent cochlear inner-hair-cell physiology. (rinne2022wholeexomesequencing pages 2-4, rinne2022wholeexomesequencing pages 1-2)
  2. Sinus bradycardia/sinoatrial-node dysfunction—reported daytime rates were approximately 38–52 beats/min, falling below 35 beats/min at night in affected homozygotes. Suggested terms: HP:0001649 Bradycardia and a suitable HPO term for sick sinus syndrome/sinus-node dysfunction. (torrente2020channelopathiesofvoltagegated pages 7-9)
  3. Sinus pauses and sinoatrial exit block—episodic manifestations superimposed on chronic bradycardia. (torrente2020channelopathiesofvoltagegated pages 7-9)
  4. Atrioventricular conduction disease—severity ranges from second-degree AV block to complete heart block. Suggested terms: HP:0011706 Second-degree atrioventricular block and HP:0004762 Complete atrioventricular block. (torrente2020channelopathiesofvoltagegated pages 7-9)
  5. Exercise intolerance, dizziness, fatigue, and syncope—downstream symptoms of bradycardia and chronotropic incompetence; exercise-associated syncope was reported. Suggested terms include HP:0001279 Syncope, fatigue, dizziness, and exercise intolerance. (torrente2020channelopathiesofvoltagegated pages 7-9)

Precise percentages cannot be responsibly assigned because published evidence lacks a complete standardized denominator. Congenital deafness and sinus-node disease define classic SANDD, whereas AV block and symptomatic syncope vary in severity.

Onset, severity, progression, and quality of life

Deafness is congenital. Cardiac disease is congenital or recognized in childhood and appears chronic, with variable severity and episodic pauses/syncope. There is no evidence for spontaneous remission. Deafness affects communication and education, while bradycardia, syncope, and exercise intolerance restrict physical activity and create injury risk. No SANDD-specific EQ-5D, SF-36, PROMIS, or hearing-related quality-of-life study was identified.

4. Genetic and molecular information

Gene and protein

CACNA1D encodes CaV1.3, an L-type voltage-gated calcium-channel α1 subunit. CaV1.3 is particularly important in adult atrial, sinoatrial, and atrioventricular nodal tissue and in cochlear inner hair cells. (mesirca2016rescuingcardiacautomaticity pages 3-5, rinne2022wholeexomesequencing pages 1-2)

Variant interpretation

  • p.Gly403dup/p.403_404insGly: homozygous germline in affected families; three-base-pair in-frame insertion; functionally electrically silent despite membrane localization. This constitutes strong pathogenic evidence from segregation, phenotype specificity, and functional assay. (torrente2020channelopathiesofvoltagegated pages 7-9, torrente2020channelopathiesofvoltagegated pages 5-7)
  • p.Ala376Val: reported in another family with the same SANDD phenotype, but the retrieved evidence provides less detailed segregation and functional information than for p.Gly403dup. (rinne2022wholeexomesequencing pages 9-11, torrente2020channelopathiesofvoltagegated pages 7-9)

Current ClinVar classifications and exact gnomAD allele counts were not recovered and should be checked against the current transcript and genome build before database ingestion. The recurrent variant’s multiple protein descriptions also require HGVS normalization against the selected CACNA1D transcript. The disease alleles are germline, not somatic.

No established chromosomal rearrangement, copy-number syndrome, repeat expansion, mitochondrial variant, modifier gene, or disease-specific epigenetic signature is known. No anticipation or germline mosaicism has been reported. Carrier frequency cannot be calculated from the family reports.

Important allelic distinction

A heterozygous p.Arg930His CACNA1D variant was reported in an autosomal-dominant family with sinus-node dysfunction, epilepsy, learning problems, and ADHD but not classic congenital deafness. It produced gain of function in the short, brain-enriched isoform and loss of function in the long isoform. This is mechanistically and clinically distinct from recessive SANDD. (rinne2022wholeexomesequencing pages 2-4, rinne2022wholeexomesequencing pages 1-2, rinne2022wholeexomesequencing pages 11-12)

5. Environmental information

No toxin, radiation exposure, pollutant, occupation, diet, smoking pattern, alcohol use, or infectious agent is known to cause classic SANDD. Such factors can independently worsen acquired bradyarrhythmia or hearing loss, but there is no evidence that they initiate the CACNA1D syndrome. Consequently, environmental and infectious-agent fields should be populated as not established/not applicable, rather than as negative causal claims.

6. Mechanism and pathophysiology

Cardiac causal chain

Upstream: biallelic CACNA1D loss of function → absent or markedly reduced CaV1.3-mediated L-type Ca²⁺ current.

Cellular: CaV1.3 normally activates at more negative voltages than CaV1.2—approximately −45 mV versus −25 mV—allowing it to contribute during diastolic depolarization of sinoatrial pacemaker cells. Under β-adrenergic activation, relevant CaV1.3 activity can extend to approximately −55 to −60 mV. CaV1.3 also supports RyR2-dependent local Ca²⁺ release and NCX-mediated inward current and contributes to sustained inward current. (torrente2020channelopathiesofvoltagegated pages 5-7, torrente2020channelopathiesofvoltagegated pages 9-11)

Downstream: reduced diastolic inward current and impaired Ca²⁺-clock/membrane-clock coupling → slowed spontaneous pacemaker depolarization → sinus bradycardia, pauses, exit block, and chronotropic incompetence. Loss of CaV1.3 in atrioventricular nodal cells similarly slows or blocks conduction. In global knockout mice, SAN L-type current density is reduced by approximately 60–70%. (mesirca2016rescuingcardiacautomaticity pages 3-5, torrente2020channelopathiesofvoltagegated pages 22-24)

Suggested GO annotations include GO:0005245 voltage-gated calcium-channel activity, GO:0006816 calcium-ion transport, cardiac action-potential regulation, membrane depolarization, regulation of heart rate, and calcium-dependent exocytosis.

Auditory causal chain

CACNA1D loss → failure of CaV1.3-mediated Ca²⁺ entry in cochlear inner hair cells → impaired presynaptic ribbon-synapse transmitter release and abnormal pre-hearing Ca²⁺ action potentials/gene-expression programs → arrested inner-hair-cell maturation, altered BK/SK2 channel expression, and eventual hair-cell degeneration → congenital severe-to-profound sensorineural deafness. (rinne2022wholeexomesequencing pages 1-2)

Suggested cells and processes are CL:0000586 hearing receptor cell, cochlear inner hair cell, sensory perception of sound, inner-ear receptor-cell differentiation, calcium-dependent exocytosis, and ribbon-synapse transmission.

Other mechanistic domains

No SANDD-specific immune, inflammatory, fibrotic, metabolic, lipidomic, metabolomic, proteomic, single-cell, spatial-transcriptomic, or epigenomic signature has been established. The primary abnormality is an ion-channel conduction defect, not inflammation or energy-metabolism failure.

7. Anatomical structures affected

  • Heart/conduction system: heart (UBERON:0000948), sinoatrial node, atrioventricular node, atrial conduction tissue; principal cells are specialized nodal pacemaker/conduction cardiomyocytes. (mesirca2016rescuingcardiacautomaticity pages 3-5, rinne2022wholeexomesequencing pages 1-2)
  • Inner ear: inner ear (UBERON:0001844), cochlea (UBERON:0001690), organ of Corti, and especially bilateral cochlear inner hair cells and their ribbon synapses. (rinne2022wholeexomesequencing pages 1-2)
  • Subcellular localization: CaV1.3 resides in the plasma membrane; disease-relevant signaling also involves presynaptic active zones/ribbon synapses, sarcolemmal ion-channel complexes, sarcoplasmic-reticulum RyR2 release sites, and NCX-containing membrane microdomains.
  • Lateralization: Hearing loss is expected to be bilateral; no consistent cardiac anatomical lateralization applies.

8. Temporal development

The auditory phenotype begins prenatally or at birth, reflecting developmental failure of inner-hair-cell function and maturation. Cardiac bradyarrhythmia is congenital/childhood-onset and chronic. Severity can fluctuate with sleep, exercise, autonomic state, and intermittent conduction block; the documented lower nocturnal heart rates illustrate physiologic modulation of an underlying fixed channel defect. (torrente2020channelopathiesofvoltagegated pages 7-9)

No validated staging system exists. A practical clinical sequence is: congenital deafness and baseline bradycardia → recognition of pauses/chronotropic incompetence or AV block → symptomatic dizziness, exercise intolerance, or syncope → pacemaker consideration. Disease duration is lifelong, and no spontaneous remission window is documented.

9. Inheritance and population

Inheritance is autosomal recessive. Heterozygous relatives in classic families were reported as phenotypically normal, suggesting that one functional allele is usually sufficient, although formal lifelong penetrance studies are unavailable. (torrente2020channelopathiesofvoltagegated pages 7-9)

The recurrent variant was found in seven consanguineous families from Khyber Pakhtunkhwa, Pakistan, consistent with a founder effect or geographically concentrated allele. No unbiased prevalence, incidence, carrier-frequency, sex-ratio, or age-distribution estimate exists. There is no evidence of sex-limited expression, anticipation, or a broad endemic distribution. (torrente2020channelopathiesofvoltagegated pages 5-7)

For counseling, when both parents are confirmed heterozygous carriers, each pregnancy has the standard autosomal-recessive probabilities: 25% affected, 50% carrier, and 25% unaffected/non-carrier.

10. Diagnostics

Clinical evaluation

  1. Cardiac: resting 12-lead ECG; prolonged Holter/event monitoring to quantify minimum and mean heart rates, sinus pauses, exit block, and AV block; exercise testing for chronotropic incompetence; echocardiography to evaluate structural heart disease and alternative causes. Electrophysiology study may be considered when noninvasive findings are inconclusive.
  2. Audiology: newborn or diagnostic auditory brainstem response, otoacoustic emissions, pure-tone audiometry when developmentally appropriate, tympanometry, speech testing, and assessment for cochlear implantation.
  3. Laboratory exclusion: electrolytes, thyroid function, medication review, and other tests directed at acquired bradycardia; these do not diagnose SANDD.

Genetic testing strategy

  • When congenital bilateral sensorineural deafness co-occurs with marked sinus bradycardia or AV block, perform CACNA1D sequencing with deletion/duplication analysis or a combined hearing-loss/arrhythmia panel.
  • WES or WGS is appropriate when the phenotype is atypical, panel testing is negative, or a second diagnosis is possible. WES identified a distinct dominant CACNA1D syndrome in a sinus-node-dysfunction cohort, illustrating the value of broad testing but also the need for mechanism-specific interpretation. (rinne2022wholeexomesequencing pages 2-4, rinne2022wholeexomesequencing pages 1-2)
  • Confirm phase and segregation by parental testing. A molecular diagnosis of recessive SANDD requires two pathogenic/likely pathogenic loss-of-function alleles in trans plus compatible phenotype.
  • CMA, karyotype, FISH, mitochondrial testing, repeat-expansion testing, RNA sequencing, proteomics, metabolomics, and liquid biopsy are not first-line unless another diagnosis is suspected.

Differential diagnosis

Important alternatives include isolated congenital deafness plus unrelated bradycardia; Jervell and Lange-Nielsen syndrome (biallelic KCNQ1/KCNE1, deafness with prolonged QT); HCN4-related sinus-node disease; SCN5A-related conduction disease; LMNA-related conduction/cardiomyopathy; mitochondrial deafness syndromes; and dominant CACNA1D neurodevelopmental/endocrine channelopathy. The ECG QT interval, neurologic/endocrine phenotype, inheritance, and molecular findings distinguish these conditions. CACNA1D’s recessive-versus-dominant allelic spectrum is analogous to other channel genes in which dosage and functional direction determine phenotype. (rinne2022wholeexomesequencing pages 9-11)

Cascade testing of relatives is appropriate; universal population or newborn genomic screening for SANDD is not established.

11. Outcome and prognosis

No disease-specific 5- or 10-year survival, mortality, life-expectancy, hospitalization, or quality-of-life estimates exist. Likely major morbidities are recurrent syncope/injury, exercise limitation, progression of conduction disease, pacemaker dependence, and lifelong communication disability. Atrial fibrillation was inducible in Cacna1d-null mice but was not reported in the summarized human SANDD cases, so it should not be coded as an established human feature. (torrente2020channelopathiesofvoltagegated pages 7-9)

Prognosis is expected to improve substantially with recognition and treatment of clinically important bradyarrhythmia and with early hearing rehabilitation, but syndrome-specific response rates are unavailable. Severity of bradycardia, pause duration, high-grade AV block, syncope, and failure of heart rate to rise with exercise are clinically relevant risk indicators; no molecular prognostic biomarker beyond causal genotype has been validated.

12. Treatment

Current real-world management

  • Permanent cardiac pacemaker: standard definitive therapy for symptomatic sinus-node dysfunction, clinically consequential pauses, chronotropic incompetence, or advanced AV block. This treats the electrical consequence but does not restore CACNA1D function or hearing. Suggested NCIT concept: cardiac pacemaker implantation. Reviews emphasize that current SND management is primarily symptomatic and that electronic pacing remains the established intervention. (mesirca2016rescuingcardiacautomaticity pages 1-2)
  • Acute symptomatic bradycardia: managed under standard resuscitation/cardiology protocols; atropine or temporary pacing may be used according to clinical context, but no SANDD-specific evidence exists.
  • Hearing care: early audiology, hearing devices when residual function permits, cochlear-implant evaluation for severe/profound loss, speech-language therapy, educational accommodations, and communication support. Syndrome-specific cochlear-implant outcomes have not been published in the recovered literature.
  • Medication review: avoid or carefully supervise drugs that further slow sinus or AV nodal function.

Experimental and precision approaches

In Cacna1d-null mice, inhibition of the acetylcholine-activated potassium current IKACh—including experimental inhibitors such as tertiapin-Q—restored a more favorable inward/outward current balance and rescued bradycardia. This is preclinical proof of concept, not approved SANDD treatment. (mesirca2016rescuingcardiacautomaticity pages 1-2, torrente2020channelopathiesofvoltagegated pages 9-11)

No SANDD-specific gene therapy, RNA therapy, CRISPR trial, cell therapy, or registered interventional clinical trial was identified. CaV1.3 blockers such as isradipine are being explored for gain-of-function CACNA1D neurodevelopmental/endocrine disease; blocking an already loss-of-function channel is not a rational SANDD treatment. In 2024 expert analysis, isradipine benefit was discussed in a gain-of-function mouse model, whereas human CaV1.3 loss of function remained a distinct bradycardia-deafness syndrome. (ortner2024iscav1.3a pages 6-6)

13. Prevention

Primary prevention by lifestyle modification, vaccination, or prophylactic medication is not possible for a germline recessive channelopathy. Relevant measures are:

  • Genetic counseling and carrier testing in affected families.
  • Reproductive options: prenatal diagnosis or preimplantation genetic testing when familial variants are known.
  • Secondary prevention: newborn hearing screening, early ECG/Holter evaluation in at-risk children, and cascade genetic testing.
  • Tertiary prevention: timely pacing to prevent bradycardic syncope and high-grade block; early hearing intervention to reduce language and educational consequences; avoidance of conduction-slowing drugs when possible.

There is no applicable vaccine, infectious prophylaxis, or population-wide public-health screening program specific to SANDD.

14. Other species and natural disease

No naturally occurring veterinary SANDD syndrome or breed-associated CACNA1D disorder was identified. The principal comparative species is the laboratory mouse, Mus musculus (NCBI Taxonomy 10090), with ortholog Cacna1d. The cardiac and cochlear functions of CaV1.3 are evolutionarily conserved, but existing mouse disease is experimentally engineered rather than naturally occurring. There is no infectious transmission or zoonotic potential.

15. Model organisms and experimental systems

Mouse models

Global Cacna1d/CaV1.3 knockout mice reproduce major human features: bradycardia, sinoatrial dysfunction, AV block, and deafness. SAN L-type Ca²⁺ current is reduced by approximately 60–70%, making this a strong mechanistic model for membrane-clock/Ca²⁺-clock coupling and for preclinical pacemaker-current interventions. (mesirca2016rescuingcardiacautomaticity pages 3-5, torrente2020channelopathiesofvoltagegated pages 7-9, torrente2020channelopathiesofvoltagegated pages 22-24)

Cochlea-specific Cacna1d deletion produces profound hearing loss, absent normal BK-channel upregulation, persistence of immature SK2 expression, and arrested inner-hair-cell differentiation. This demonstrates a cochlea-autonomous requirement for CaV1.3, although complex Cre/reporter constructs can themselves alter expression or cause GFP toxicity and therefore require careful controls. (rinne2022wholeexomesequencing pages 1-2)

In-vitro systems

Heterologous channel-expression and patch-clamp studies show that the recurrent p.Gly403dup protein reaches the cell surface but produces no measurable Ca²⁺ current. These assays provide direct evidence of loss of channel conductance but do not reproduce the multicellular architecture or autonomic regulation of the SAN and cochlea. (torrente2020channelopathiesofvoltagegated pages 7-9, torrente2020channelopathiesofvoltagegated pages 5-7)

No validated SANDD patient-derived iPSC pacemaker-cell model, cochlear organoid, large-animal model, CRISPR screen, or disease-specific multi-omics model was identified in the retrieved evidence.

Recent developments and expert assessment, 2023–2024

Recent cardiac reviews continue to identify CaV1.3 as unusually attractive for nodal-selective mechanistic study because adult cardiac expression is concentrated in atrial and nodal tissue rather than being ubiquitous across ventricular myocardium. Nonetheless, therapeutic work in 2023–2024 has focused more heavily on CACNA1D gain-of-function neurodevelopmental disease than on SANDD. The emerging expert consensus is therefore that molecular direction matters: CaV1.3 inhibition may be relevant to gain-of-function disease, whereas SANDD requires restoration or compensation of deficient pacemaker and cochlear signaling. (ortner2024iscav1.3a pages 6-6)

The most mature SANDD-relevant translational idea remains compensatory ion-channel targeting, exemplified by IKACh inhibition in knockout mice. Gene replacement or editing is conceptually attractive but faces the challenge of delivering therapy to two specialized targets—cardiac nodal cells and cochlear inner hair cells—potentially during different developmental windows. (mesirca2016rescuingcardiacautomaticity pages 1-2, torrente2020channelopathiesofvoltagegated pages 9-11)

Key sources, dates, and URLs

  1. Baig et al. “Loss of CaV1.3 (CACNA1D) function in a human channelopathy with bradycardia and congenital deafness.” Nature Neuroscience. Published December 2010/January 2011 issue. PMID 21131953. DOI: https://doi.org/10.1038/nn.2694. This is the landmark primary human report underlying the disease association. (OpenTargets Search: Sinoatrial node dysfunction and deafness-CACNA1D)
  2. Torrente et al. “Channelopathies of voltage-gated L-type CaV1.3/α1D and T-type CaV3.1/α1G Ca²⁺ channels in dysfunction of heart automaticity.” Pflügers Archiv. Published June 2020. DOI: https://doi.org/10.1007/s00424-020-02421-1. (torrente2020channelopathiesofvoltagegated pages 5-7, torrente2020channelopathiesofvoltagegated pages 7-9)
  3. Mesirca et al. “Rescuing cardiac automaticity in L-type CaV1.3 channelopathies and beyond.” Journal of Physiology. Published October 2016. DOI: https://doi.org/10.1113/JP270678. (mesirca2016rescuingcardiacautomaticity pages 3-5, mesirca2016rescuingcardiacautomaticity pages 1-2)
  4. Rinné et al. “Whole Exome Sequencing Identifies a Heterozygous Variant in the CaV1.3 Gene CACNA1D Associated with Familial Sinus Node Dysfunction and Focal Idiopathic Epilepsy.” International Journal of Molecular Sciences. Published November 2022. DOI: https://doi.org/10.3390/ijms232214215. Its abstract states: “So far, homozygous loss of function mutations in CACNA1D encoding the CaV1.3 α1-subunit are described in congenital sinus node dysfunction and deafness.” This source is especially useful for separating classic SANDD from dominant mixed-effect disease. (rinne2022wholeexomesequencing pages 2-4, rinne2022wholeexomesequencing pages 1-2)
  5. Ortner. “Is CaV1.3 a feasible therapeutic target for a rare neurodevelopmental disorder?” Expert Opinion on Therapeutic Targets. Published December 2024. DOI: https://doi.org/10.1080/14728222.2024.2442428. This is authoritative recent analysis but pertains primarily to CACNA1D gain-of-function disease, not SANDD therapy. (ortner2024iscav1.3a pages 6-6)

Evidence limitations

SANDD has not been characterized through registries, prospective natural-history cohorts, randomized trials, or population screening. Consequently, disease prevalence, incidence, exact phenotype frequencies, penetrance by age, carrier frequency, sex ratio, survival, mortality, quality-of-life scores, cochlear-implant outcomes, and genotype-specific prognosis remain unknown. Database fields for those domains should be marked “not available—ultra-rare family-level evidence”, not zero. The most secure knowledge-base assertions are the MONDO/OMIM mapping, recessive CACNA1D loss-of-function mechanism, congenital deafness, severe sinus bradycardia with possible AV block, and recapitulation in Cacna1d-null mice. (OpenTargets Search: Sinoatrial node dysfunction and deafness-CACNA1D, torrente2020channelopathiesofvoltagegated pages 5-7, torrente2020channelopathiesofvoltagegated pages 7-9)

References

  1. (OpenTargets Search: Sinoatrial node dysfunction and deafness-CACNA1D): Open Targets Query (Sinoatrial node dysfunction and deafness-CACNA1D, 1 results). Buniello, A. et al. (2025). Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery. Nucleic Acids Research.

  2. (torrente2020channelopathiesofvoltagegated pages 5-7): Angelo G. Torrente, Pietro Mesirca, Isabelle Bidaud, and Matteo E. Mangoni. Channelopathies of voltage-gated l-type cav1.3/α1d and t-type cav3.1/α1g ca2+ channels in dysfunction of heart automaticity. Pflügers Archiv - European Journal of Physiology, 472:817-830, Jun 2020. URL: https://doi.org/10.1007/s00424-020-02421-1, doi:10.1007/s00424-020-02421-1. This article has 32 citations.

  3. (rinne2022wholeexomesequencing pages 2-4): Susanne Rinné, Birgit Stallmeyer, Alexandra Pinggera, Michael F. Netter, Lina A. Matschke, Sven Dittmann, Uwe Kirchhefer, Ulrich Neudorf, Joachim Opp, Jörg Striessnig, Niels Decher, and Eric Schulze-Bahr. Whole exome sequencing identifies a heterozygous variant in the cav1.3 gene cacna1d associated with familial sinus node dysfunction and focal idiopathic epilepsy. International Journal of Molecular Sciences, 23:14215, Nov 2022. URL: https://doi.org/10.3390/ijms232214215, doi:10.3390/ijms232214215. This article has 22 citations.

  4. (rinne2022wholeexomesequencing pages 1-2): Susanne Rinné, Birgit Stallmeyer, Alexandra Pinggera, Michael F. Netter, Lina A. Matschke, Sven Dittmann, Uwe Kirchhefer, Ulrich Neudorf, Joachim Opp, Jörg Striessnig, Niels Decher, and Eric Schulze-Bahr. Whole exome sequencing identifies a heterozygous variant in the cav1.3 gene cacna1d associated with familial sinus node dysfunction and focal idiopathic epilepsy. International Journal of Molecular Sciences, 23:14215, Nov 2022. URL: https://doi.org/10.3390/ijms232214215, doi:10.3390/ijms232214215. This article has 22 citations.

  5. (rinne2022wholeexomesequencing pages 9-11): Susanne Rinné, Birgit Stallmeyer, Alexandra Pinggera, Michael F. Netter, Lina A. Matschke, Sven Dittmann, Uwe Kirchhefer, Ulrich Neudorf, Joachim Opp, Jörg Striessnig, Niels Decher, and Eric Schulze-Bahr. Whole exome sequencing identifies a heterozygous variant in the cav1.3 gene cacna1d associated with familial sinus node dysfunction and focal idiopathic epilepsy. International Journal of Molecular Sciences, 23:14215, Nov 2022. URL: https://doi.org/10.3390/ijms232214215, doi:10.3390/ijms232214215. This article has 22 citations.

  6. (mesirca2016rescuingcardiacautomaticity pages 1-2): Pietro Mesirca, Isabelle Bidaud, and Matteo E. Mangoni. Rescuing cardiac automaticity in l‐type cav1.3 channelopathies and beyond. The Journal of Physiology, 594:5869-5879, Oct 2016. URL: https://doi.org/10.1113/jp270678, doi:10.1113/jp270678. This article has 31 citations.

  7. (torrente2020channelopathiesofvoltagegated pages 7-9): Angelo G. Torrente, Pietro Mesirca, Isabelle Bidaud, and Matteo E. Mangoni. Channelopathies of voltage-gated l-type cav1.3/α1d and t-type cav3.1/α1g ca2+ channels in dysfunction of heart automaticity. Pflügers Archiv - European Journal of Physiology, 472:817-830, Jun 2020. URL: https://doi.org/10.1007/s00424-020-02421-1, doi:10.1007/s00424-020-02421-1. This article has 32 citations.

  8. (torrente2020channelopathiesofvoltagegated pages 22-24): Angelo G. Torrente, Pietro Mesirca, Isabelle Bidaud, and Matteo E. Mangoni. Channelopathies of voltage-gated l-type cav1.3/α1d and t-type cav3.1/α1g ca2+ channels in dysfunction of heart automaticity. Pflügers Archiv - European Journal of Physiology, 472:817-830, Jun 2020. URL: https://doi.org/10.1007/s00424-020-02421-1, doi:10.1007/s00424-020-02421-1. This article has 32 citations.

  9. (mesirca2016rescuingcardiacautomaticity pages 3-5): Pietro Mesirca, Isabelle Bidaud, and Matteo E. Mangoni. Rescuing cardiac automaticity in l‐type cav1.3 channelopathies and beyond. The Journal of Physiology, 594:5869-5879, Oct 2016. URL: https://doi.org/10.1113/jp270678, doi:10.1113/jp270678. This article has 31 citations.

  10. (torrente2020channelopathiesofvoltagegated pages 9-11): Angelo G. Torrente, Pietro Mesirca, Isabelle Bidaud, and Matteo E. Mangoni. Channelopathies of voltage-gated l-type cav1.3/α1d and t-type cav3.1/α1g ca2+ channels in dysfunction of heart automaticity. Pflügers Archiv - European Journal of Physiology, 472:817-830, Jun 2020. URL: https://doi.org/10.1007/s00424-020-02421-1, doi:10.1007/s00424-020-02421-1. This article has 32 citations.

  11. (ortner2024iscav1.3a pages 6-6): Nadine J. Ortner. Is cav1.3 a feasible therapeutic target for a rare neurodevelopmental disorder? Expert Opinion on Therapeutic Targets, 28:1021-1025, Dec 2024. URL: https://doi.org/10.1080/14728222.2024.2442428, doi:10.1080/14728222.2024.2442428. This article has 0 citations and is from a peer-reviewed journal.

  12. (rinne2022wholeexomesequencing pages 11-12): Susanne Rinné, Birgit Stallmeyer, Alexandra Pinggera, Michael F. Netter, Lina A. Matschke, Sven Dittmann, Uwe Kirchhefer, Ulrich Neudorf, Joachim Opp, Jörg Striessnig, Niels Decher, and Eric Schulze-Bahr. Whole exome sequencing identifies a heterozygous variant in the cav1.3 gene cacna1d associated with familial sinus node dysfunction and focal idiopathic epilepsy. International Journal of Molecular Sciences, 23:14215, Nov 2022. URL: https://doi.org/10.3390/ijms232214215, doi:10.3390/ijms232214215. This article has 22 citations.

Artifacts